key: cord-0576191-m472ntz1
authors: Chen, Zhe Sage; Kulkarni, Prathamesh; Galatzer-Levy, Isaac R.; Bigio, Benedetta; Nasca, Carla; Zhang, Yu
title: Modern Views of Machine Learning for Precision Psychiatry
date: 2022-04-04
journal: nan
DOI: nan
sha: d4c200c899a585669a8e5d9ae10b54b3c99983ce
doc_id: 576191
cord_uid: m472ntz1

In light of the NIMH's Research Domain Criteria (RDoC), the advent of functional neuroimaging, novel technologies and methods provide new opportunities to develop precise and personalized prognosis and diagnosis of mental disorders. Machine learning (ML) and artificial intelligence (AI) technologies are playing an increasingly critical role in the new era of precision psychiatry. Combining ML/AI with neuromodulation technologies can potentially provide explainable solutions in clinical practice and effective therapeutic treatment. Advanced wearable and mobile technologies also call for the new role of ML/AI for digital phenotyping in mobile mental health. In this review, we provide a comprehensive review of the ML methodologies and applications by combining neuroimaging, neuromodulation, and advanced mobile technologies in psychiatry practice. Additionally, we review the role of ML in molecular phenotyping and cross-species biomarker identification in precision psychiatry. We further discuss explainable AI (XAI) and causality testing in a closed-human-in-the-loop manner, and highlight the ML potential in multimedia information extraction and multimodal data fusion. Finally, we discuss conceptual and practical challenges in precision psychiatry and highlight ML opportunities in future research.

M ENTAL health is epidemic in the United States and the world. According to the National Institute of Mental Health (NIMH), nearly one in five American adults suffer from a form of mental illness or psychiatric disorder (www.nimh.nih.gov/health/statistics/). According to the Centers for Disease Control and Prevention (CDC), The COVID-19 pandemic has witnessed a significant impact on our lifestyle, and considerably elevated adverse mental health conditions caused by fear, worry and uncertainty [1] . Increased suicide rates, opioid abuse, antidepressant usage have been observed in both adults and teenagers. The diagnosis and treatment of mental health has imposed a burden to the healthcare system and the society. For instance, the economic burden of depression alone is estimated to be at least $210 billion annually (www.workplacementalhealth. *Corresponding authors: zhe.chen@nyulangone.org (Z.S. Chen, ORCID: 0000-0002-6483-6056) and yuzi20@lehigh.edu (Y. Zhang, ORCID: 0000-0003-4087-6544) org/mental-health-topics/depression/). Precision medicine (or personalized medicine) is an innovative approach to tailoring disease prevention, diagnosis, and treatment that account for the differences in subjects' genes, environments, and lifestyles. The goal of precision medicine is to target timely and accurate diagnosis/prognosis/therapeutics for individualized patient's health problem, and further provide feedback information to patients and surrogate decision-makers. Recent decades have witnessed various degrees of successes in precision medicine, especially in oncology (Lancet, vol. 397, 2021, p. 1781). Traditional diagnoses of mental illnesses rely on physical exam, lab tests, psychological and behavioral evaluation. Meanwhile, precision psychiatry has increasingly received its deserved attention in the field [2] , [3] . Although psychiatry has not yet benefited fully from the advanced diagnostic and therapeutic technologies that have an impact on other clinical specialties, these technologies have the potential to transform the future psychiatric landscape.

The NIMH's RDoC (Research Domain Criteria) initiative aims to address the heterogeneity of mental illness and provide a biologically-based (as opposed to symptombased) framework for understanding these mental illnesses in terms of varying degrees of dysfunction in general psychological or neurobiological systems; it attempts to bridge the power of modern multidisciplinary (such as in genetics, neuroscience, and behavioral science) research approaches [4] . In contrast, the DSM (Diagnostic and Statistical Manual of Mental Disorders) maintained by the American Psychiatric Association (APA), the assessment of diagnosis and treatment outcome in mental disorders are often based on the clinician's observations, behavioral symptoms and arXiv:2204.01607v1 [cs. LG] 4 Apr 2022 patient reporting, which is susceptible to a high degree of variability. Therefore, it is imperative to develop quantitative neurobiological markers for mental disorders while accounting for their heterogeneity and comorbidity.

One important goal in neuropsychiatry research is to identify the relationship between neurobiological/neurophysiological findings and clinical behavioral/self-report observations. Machine learning (ML) and artificial intelligence (AI) have generated growing interest in psychiatry because of their strong predictive power and generalization ability, which show promising medicine applications in prognosis and diagnosis [5] - [7] . The interest of applying ML/AI in psychiatry has grown steadily in the past two decades, as reflected in the number of PubMed publications (Fig. 1A) . To improve mental health outcome with digital technologies, the so-called "digital psychiatry" is focused on developing ML/AI methods intelligence for assessing, diagnosing, and treating mental health issues [8] . A recent global survey indicated that psychiatrists were somewhat skeptical that AI could replace human empathy, but many predicted that 'man and machine' would increasingly collaborate in undertaking clinical decisions, and they were optimistic that AI might improve efficiencies and access to care, and reduce costs [9] .

The past two decades have witnessed substantial growth of ML applications for psychiatry in the literature, reflected in applications and reviews [10] - [20] . Although multiple reviews of ML for psychiatry are available, the majority of reviews are restricted to relatively narrow scopes. In this paper, we try to provide a comprehensive review of ML and ML-powered technologies in mental health applications. Our view is "modern" in a sense that the development of new technologies, consumer market demand and public health crises (such as have constantly redefined the role of ML and reshaped our thinking in the field of precision psychiatry. Specifically, we will cover stateof-the-art technological and methodological developments in ML, multimodal neuroimaging, neuromodulation, largescale circuit modeling and human-machine interface. It is noteworthy that our reviewed literature is by no means exhaustive due to space limitation. To distinguish our review from others, we will focus on several issues central to the ML applications for psychiatry: generalizability, interpretability, causality, clinical and behavioral integration.

Our view towards this research direction is optimistic for several reasons: first, with the growing amount of data and computational power, there is an emerging demand for psychiatrists to use ML to reevaluate clinical, behavioral and neuroimaging data. Additionally, the past few years have witnessed a substantially growing interest in mental health funding within the industry (Fig. 1B) . Second, it is becoming increasingly important to leverage the power of ML and develop explainable artificial intelligence (XAI) tools for unbiased risk diagnosis, personalized medicine recommendation, and neurostimulation. Advances in neuroimaging have provided improved spatial and temporal resolution to examine brain activity; the integration of ML with neuroimaging can potentially lead to further advances that help us identify and validate biomarkers in diagnosis and treatment of mental illnesses. Third, there is an increasing demand of psychiatrists in the US, and the shortage is par- ticularly acute in poorer countries [21] . ML/AI technologies may change the practice of psychiatry for both clinicians and patients. Finally, new advanced technologies such as social media, multimedia (speech and vision), mobile and wearable devices also call for the development of ML/AI tools to assist the assessment, diagnosis or treatment of patients who are mentally ill or at risk. From now on, we will use ML and AI interchangeably throughout the paper.

The rest of the paper is organized as follows. Section 2 will present a brief background of modern neuroimaging technologies. Section 3 will explain why and how ML methods can help psychiatry. We will also provide a few case studies to illustrate the power of these methods. Section 4 will review various ML-powered technologies for psychiatry. In Section 5, we will discuss multimodal data fusion methods in diagnostic analytics. Section 6 will discuss ML applications for discovering molecular biomarkers for precision psychiatry. Section 7 will discuss XAI, causality validation and computational modeling approaches in psychiatry. Finally, we will discuss the research challenges and outstanding questions, and conclude the paper in Section 8.

The brain is a physical organ, which provides the center that supports all cognitive functions. It can be considered as the hardware of the human body. In contrast, the mind is abstract; it creates emotions and enables consciousness, perception, thinking, judgment, and memory. The World Health Organization (WHO) defines mental health as "a state of well-being in which the individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to his or her community." Psychiatry is seeking to measure the mind, which is not quite the same thing as the brain; therefore, it relies on the quantification of how people feel under specific tasks or behavioral conditions. Psychiatry disorders are often described as disorders of the mind, which disrupt the brain's ability to function normally to complete certain processes. For instance, anxiety, stress, depression, autism, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD) are categorized by varying degrees of psychomotor, cognitive, affective, and volitional impairment. Since mind and brain are internally interleaved, the syndromes of mental disorders are associated with the abnormality of the mind and brain [23] , or to be more precise, as syndromes of disrupted neural, cognitive, and behavioral systems [2] .

Human neuroimaging provides a window to examine a healthy and diseased brain, in terms of both structural and functional forms. Advances in neuroimaging techniques offer increasing scale and resolutions to examine brain activity at macroscopic, mesoscopic, and microscopic scales with various temporal and spatial resolutions (Fig. 1C) .

Our understanding of brain and behavior relationships has expanded exponentially over the last few decades. While this improvement may be attributed to a multitude of factors, advancement in neuroimaging has played a prominent role [24] . Modern-day advancements in neuroimaging have provided an increased ability to connect neuroanatomical structure and function with clinical presentations, refining our understanding of associations of specific neural regions and circuits with cognition and behavior, which in turn has led to improvements in clinical practice [25] . The rapidly advancing field of neuroimaging has allowed scientists to examine brain processes in new and exciting ways. Ranging from increased utilization of structural neuroimaging techniques to the significant scientific advancements brought about by the increased availability of functional neuroimaging, these technologies have provided significant benefits to advance the understanding of neural correlates and to the discovery of neurobiological markers in psychiatric disorders [26] , [27] . Some of the most common neuroimaging methods include the utilization of magnetic resonance imaging (MRI), functional MRI (fMRI), diffusion tensor imaging (DTI), electroencephalography (EEG), Magnetoencephalography (MEG), electrocorticography (ECoG), Functional Near-Infrared Spectroscopy (fNIRS), and positron emission tomography (PET) to probe brain function and understand the neurobiological mechanism underlying various psychiatric conditions. • MRI. MRI is a non-invasive imaging technology that produces three-dimensional detailed anatomical images and has been widely used in clinics for diagnosis, staging, and follow-up of brain disease [28] . • DTI. DTI is a technological advancement that allows researchers and clinicians to assess human white matter pathways in vivo [29] . DTI has shown its promise in characterizing neuroanatomical connectivity underlying white matter tracts, which is hard to be captured by MRI. • fMRI. fMRI is a hemodynamic technique that uses MR imaging to measure brain functional activity; it works by detecting the small regional changes in blood oxygenation and flow, known as blood oxygenation level-dependent (BOLD) signals, occurring in response to neural activity [30] . Due to the excellent spatial resolution, fMRI has been extensively used for studying neurobiological basis of various psychiatric disorders. • PET. PET is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and other physiological activities including blood flow, regional chemical composition, and absorption. The successful application of PET has been reported in biomarker studies for psychotic disorders [31] . • EEG. EEG is a non-invasive neuroimaging technique to measure electrical activity from neuronal populations via electrodes on the scalp. Due to its low cost and ease of data collection, EEG provides a practical tool to be used in a variety of clinical environments [32] . • MEG. MEG is an imaging technique that uses sensitive devices called superconducting quantum interference devices to measure the magnetic fields produced by electrical activity in the brain. MEG is less affected by secondary currents and demonstrates superior spatial resolution compared with EEG [33] . • ECoG. ECoG can be viewed as invasive intracranial EEG that measures brain signals from the cortical surface. Because the subdural electrodes are placed directly on the cortical surface, the ECoG signals have better signal-tonoise ratio (SNR) and excellent spatial and spectral resolution compared with EEG [34] . ECoG has a long history of use in clinical neurosurgery since its initial application in epilepsy surgery, and has been recently used in research studies of mental disorders, such as depression and mood disorders [35] , [36] . Micro-ECoG (µECoG) utilizes microscale electrodes with contact site diameters many orders of magnitude smaller than traditional clinical ECoG electrode sites and minimized inter-electrode spacing, allowing for even greater spatial resolution of the measured brain signals. • fNIRS. fNIRS is an optical brain monitoring technique that uses near-infrared spectroscopy to measure cortical hemodynamic activities for functional neuroimaging [37] . Alongside EEG, fNIRS can also be used in portable settings for studying psychiatric disorders [38] .

The rich neuroimaging modalities allow us to comprehensively probe brain functions. Numerous research efforts have been devoted to revealing the neurobiological basis of various psychiatric disorders using sophisticated neuroimaging analyses. These research efforts have focused on the following aspects.

• Task-related brain activation. Under specifically designed cognitive paradigms, the collected neuroimaging data enable us to examine brain activities associated with certain experimental tasks and study their relationship with cognitive dysfunctions. Typical measures of taskrelated brain activities include event-related potential and event-related spectral perturbation, and reward or emotional processing-related functional activation [39] , [40] . • Brain structural and functional connectivity. A promising direction for probing brain function using neuroimaging is to investigate brain connectivity (also brain networks or connectome) [41] . Studying the resting-state brain connectome provides a promising way to characterize the complex brain architecture and uncover brain dysfunctions in intrinsic brain networks [42] . • Brain dynamics. Increasing neuroimaging studies suggest that functional connectivity may fluctuate, rather than being stationary during an entire session of data collection [43] . Studies examining spatiotemporal dynamics of brain networks have recently received increasing attention and may reveal meaningful brain states associated with different psychiatric conditions [44] . • Multimodal neuroimaging. Another promising approach to establish robust biomarkers for psychiatry is to combine multiple neuroimaging modalities. Multimodal neuroimaging analysis offers opportunities to exploit crossmodality complementary information that a single modality approach may not capture [45] .

In the remaining sections, we argue that neuroimaging, when combined with modern ML and other ML-powered technologies, can provide powerful tools in advancing diagnosis, prognosis, and intervention of psychiatric disorders.

The nature and etiology of mental illnesses remain unclear and challenging to study. Psychiatric disorders are typically diagnosed according to a combination of clinical symptoms based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) or the International Classification of Diseases (ICD). Traditional studies for the neurobiology of psychiatric disorders have followed a categorical classification framework based on a case-control design whereby all patients with a given diagnosis are compared with healthy individuals. This framework largely relies on clinically derived diagnostic labels, assuming that a biomarker may differ enough between healthy people and patients. The symptom-based diagnosis covered hundreds of thousands of different symptom combinations, which has caused extensive clinical heterogeneity [46] , [47] . It is increasingly recognized that existing clinical diagnostic categories could misrepresent the causes underlying mental disturbance and the case-control study design has limited strength in delineating the significant clinical and neurobiological heterogeneity of psychiatric disorders, thereby hindering the understanding of psychopathology and the search for biomarkers. Previous studies have broadly explored the group effects of neurobiology to explain its connection to behavior and disease on the populational level. The widely used group-level analyses do not fully capture individual variability, but this variability is crucial for developing personalized medicine and better understanding the neural correlates of individual brain abnormalities. In addition, many psychiatric disorders may be considered as falling along multiple dimensions. Co-occurrence of multiple psychiatric disorders might reflect different patterns of symptoms that result from shared risk factors and perhaps the same underlying disease processes. The high comorbidity in these disorders significantly affects the characterization of psychopathology according to the traditional diagnostic categories. Conventional studies focusing on a single diagnostic domain will therefore prevent us from uncovering the neural correlates of comorbidity among multiple disorders and essentially identify the dimensions of neural circuits and behavioral phenotypes.

Distinct from the traditional case-control design, the NIMH's RDoC aims to address the heterogeneity and comorbidity in psychiatry by linking symptom dimensions with biological systems, cutting across the diagnostic spectrum [48] . The ultimate goal of RDoC is to find "new ways of classifying psychiatric diseases based on multiple dimensions of biology and behavior" [49] . These newly defined disease dimensions could further be utilized to discover neurobiological phenotypes and clarify the causal mechanism underlying the associated brain dysfunctions. To achieve this important vision, new analytical approaches are urgently needed. Thanks to the advancement in cuttingedge techniques in ML/AI, psychiatrists and investigators now have an unprecedented opportunity to benefit from complex patterns in brain, behavior, and genes using machine learning tools [5] . Combining these analysis techniques with rich multimodal data from increasing largescale multi-center cohorts holds significant promise in advancing a biologically grounded redefinition of psychiatric disorders.

Despite rapid progresses in the past decade, several areas appear highly underexplored but may carry the substantial potential for achieving breakthroughs in psychiatry studies. The capacity to identify individual neurobiological characteristics and dissect inter-and intra-individual variability is a crucial step toward personalized medicine and better understanding the neural basis of variation in human cognition and behavior [50] . Studies and analytic approaches focusing on the level of the individual may find greater success over conventional group-level studies. Translational study-orientated approaches for psychiatric neuroimaging may further enhance the ability to find statistically significant effect sizes that can be used in individuals [51] . On the other hand, identifying subgroups (i.e., subtypes) in psychiatric disorders provides us with a promising way to delineate neurobiological and clini- cal heterogeneity. Increasing evidence suggests that datadriven subtyping could drive novel neurobiological phenotypes associated with distinctive behavior and cognitive functioning [52] . These stratified phenotypes may further show improved predictability for clinical outcomes than DSM/ICD diagnoses can and serve as potential markers for treatment selection [53] . Another promising area focuses on transdiagnostic approaches to uncover neural correlates of specific domains, such as cognition, arousal, and emotion regulation, which are implicated in psychopathology across the diagnostic spectrum [54] . By leveraging advanced ML tools, recent efforts have been dedicated to identifying transdiagnostic brain dysfunctions and dimensions of psychopathology [55] - [58] . Additionally, leveraging "big data" from a longitudinal perspective offers a promising way to track the trajectories of neural phenotypes that have been rarely examined in previous cross-sectional studies of psychiatric disorders [59] - [61] . Investigating the association between the trajectories of neural phenotypes and cognitive or behavioral dysfunctions across different stages of the disease may further reveal the neural mechanism underlying the disease progression and psychopathology, thereby providing new insights for the development of targeted interventions. These new frontiers in studying psychiatric disorders can be substantially empowered by modern ML methodologies summarized in Table 1 , with demonstrated potential to stratify patients into clinically meaningful subtypes, discover novel transdiagnostic disease dimensions crossing diagnostic boundaries, and tailor treatment decisions to individual patients. The research outcome can deliver a significant promise in promoting the development of objective neurobiological markers-based precision medicine in psychiatry.

In the application domain, ML can be used in four types of applications in mental illnesses: diagnosis, prognosis, treatment, and readmission. In contrast to most medical disciplines, traditional diagnoses in psychiatry remain restricted to subjective symptoms and observable signs. The limitations of this clinical practice have been criticized and the field has called for a paradigm shift in precision psychiatry. In the following subsections, we will review several key ML paradigms in mental health applications based on neuroimaging, behavioral and clinical measurements. A tabular review of representative applications is shown in Table 2 . In this section, we will focus on the review of ML in psychiatry based on neuroimaging data, but the ML applications can also cover other types of data, such as genetic, clinical, behavioral, and social media data. Detailed reviews of the other data domains will be reviewed separately in later sections.

ML holds substantial promise in promoting the research from small case-control studies to large transdiagnostic samples, from prior specified brain regions to whole-brain circuit dysfunction for individual-level precision medicine [24] , [98] , [99] . In a new era of evidence-based psychiatry tailored to individual patients, objectively measurable endophenotypes identified using advanced data-driven approaches could allow for early disease detection, personalized treatment selection, and dosage adjustment to reduce the burden of disease [10] , [100] , [101] . These significantly promising applications in psychiatric disorders have become possible by leveraging the powerful strength of modern machine learning techniques [13] , [102] - [104] .

Supervised Learning. Supervised learning, as the most popularly used category, has been widely applied to neuroimaging-based predictive modeling tasks in psychiatric disorders [105] . These classic machine learning algorithms include logistic regression, support vector machine, and random forest. Given the high-dimensional nature of neuroimaging data, these approaches are commonly accompanied by a feature selection step to obtain lowdimensionality representations. Connectome-based predictive modeling [106] , [107] is one of such approaches that combine simple linear regression and feature selection to predict individual differences in traits and behavior from connectivity data. LASSO provides an alternative approach that embeds feature selection into the prediction model training to learn a compact feature pattern for the accurate prediction of a specialized brain disease or clinical outcome [92] . Relevance vector machine (RVM) is an approach built upon a probabilistic framework by leveraging automatic relevance determination (ARD) to learn a sparse solution and penalize unnecessary complexity in the model [108] , [109] . RVM has recently demonstrated its strength in quantifying neuroimaging biomarkers for the diagnosis of PTSD [67] and for the prediction of depression [86] . As an extension of the conventional single-task methods, multi-task learning approaches have been increasingly designed to exploit the complementary features jointly from multiple views of neuroimaging data [110] - [112] .

Due to the complex nature of brain function, informative features may not be observable in the raw high- [97] dimensional feature space. To address this challenge, latent space-based supervised learning has been increasingly applied to uncover latent dimensions of neural circuits in psychiatric disorders. For example, a sparse latent space regression model was developed and tailored for EEG data to discover antidepressant responsive brain signatures in major depression [85] . By jointly learning the spatial mapping and regression weights, the machine learning model was able to successfully amplify the signal-tonoise ratio and quantify treatment-predictive signatures in a low-dimensional latent space. To address the comorbidity among psychiatric disorders, dimensional approaches have been developed using powerful multivariate statistical models capable of discovering the complex linear relationship between high-dimensional datasets. For instance, low-dimensional representations of depression-related connectivity features have been successfully identified using canonical correlation analysis (CCA) between resting-state fMRI (rs-fMRI) connectivity and clinical symptoms [52] . These newly discovered representations defined two disease dimensions corresponding to an anhedonia-related component and an anxiety-related component, respectively. Similar dimensional analysis was also utilized to examine the neural correlates of neuropsychiatric symptoms in dementia and captured latent modes with the distinct neuroanatomical basis of common and mood-specific factors [113] . A sparsity-constrained CCA approach has been applied to reveal linked dimensions of psychopathology and functional connectivity in brain networks [56] . This approach sucessfully identified interpretable dimensions involving mood, psychosis, fear, and externalizing behavior guided by neural circuit patterns across the clinical diagnostic spectrum. The partial least squares (PLS) approach was also applied to identify latent components linking a broader set of behavioral measures to whole-brain resting-state functional connectivity [57] . The latent components defined distinct dimensions with dissociable brain functional signatures, providing potential intermediate phenotypes spanning diagnostic categories. These new dimensional analytics hold substantial promise in uncovering novel transdiagnostic phenotypes for the development of targeted interventions. Ensemble Learning. Though extensive ML approaches have been designed for supervised learning, using a single model may not produce the optimal generalization performance for a specific prediction task. By combining multiple ML models to decrease variance and bias, ensemble learning improves prediction performance over a single model and has demonstrated successful applications in the robust discovery of biomarkers for various psychiatric disorders. For instance, multiple brain parcellation ensemble-learning algorithms have been proposed for improved schizophrenia detection [114] and ASD diagnosis [65] . By utilizing multimodal neuroimaging including sMRI, fMRI, and DTI, a bagging-based SVM was devised to yield a significant improvement in the prediction of adult outcomes in childhoodonset ADHD [63] . Based on the selective ensemble algorithm, a sparse multi-view prediction model has been designed with rs-fMRI connectivity for ASD diagnosis [115] . The model combines multiple classifiers under a bootstrap framework and significantly outperformed other singlemodel approaches for ASD detection.

Unsupervised Learning. Unsupervised learning aims to uncover the intrinsic data structure by either identifying potential clusters (e.g., using latent class analysis or K-means clustering) or learning a feature mapping that captures the most variance of the data (e.g., using PCA). Identifying patient subtypes offers a promising strategy to delineate neurobiological heterogeneity in psychiatric disorders [46] . With rs-fMRI, hierarchical clustering was applied to successfully identify four subtypes of functional connectivity in depression [52] . These subtypes were found to correlate with differing clinical-symptom profiles and predict responsiveness to brain stimulation therapy. From rs-EEG, two psychiatric subtypes were identified using sparse Kmeans clustering with distinct power envelope connectivity patterns and found to respond differently to antidepressant medication and psychotherapy [53] . As a non-distance probability-based clustering approach, latent class analysis has also been applied to discover homogeneous subgroups in psychiatric disorders. A proof-of-concept study was conducted using latent class analysis to identify ADHD subtypes from fMRI activation profiles [74] and reveal that the subtype with attenuated brain activity showed fewer behavior problems in daily life. By leveraging data resources from multiple time points, psychiatry studies have been shifting from cross-sectional analysis to longitudinal modeling [24] . Finite mixture modeling became increasingly popular for the analysis of longitudinally repeated measures data, which can identify latent classes following similar paths of temporal development [116] , [117] . Typical finite mixture models include growth mixture modeling, groupbased trajectory modeling, and latent transition analysis. The use of latent growth mixture modeling (LGMM) and group-based trajectory modeling has been growing in various psychiatric disorders, such as depression, anxiety, and ASD, as flexible ways of identifying latent subpopulations that manifest heterogeneous symptom trajectories [118] - [120] . LGMM approaches have also been successfully used to predict PTSD course among the population at risk [121] . As an extension of latent class analysis to longitudinal data, latent transition analysis has been applied to predict longitudinal service use for individuals with substance use disorder [122] . Together, these approaches provide powerful tools to delineate longitudinal heterogeneity and the corresponding distinctive phenotypes during the course of psychiatric disorders.

Another way to characterize the heterogeneity can be achieved by quantifying individual deviations using unsupervised normative modeling [123] . Through building a normative model on a large-scale healthy population, brain abnormalities of individual patients can be quantified by examining their statistical differences from the distribution of the norm. Gaussian process (GP) regressionbased normative modeling has been increasingly applied to quantify individual deviations and dissect neurobiological heterogeneity in various psychiatric disorders [124] . With this tool, an association was successfully discovered between transdiagnostic dimensions of psychopathology and individual's unique deviations from normative neurodevelopment in brain structure [75] . By combining tolerance interval-based normative modeling and clustering analysis, individual abnormities in rs-fMRI were quantified to define two stable subtypes in patients with PTSD [73] . These subtypes showed distinct patterns of functional connectivity with respect to healthy people and differed clinically on levels of reexperiencing symptoms. These studies provide novel data-driven approaches to delineate heterogeneity within patients, thereby advancing clinical and mechanistic investigations in psychiatric disorders.

Semi-supervised Learning. Semi-supervised learning is an ML approach that combines a small amount of labeled data with a large amount of unlabeled data during training. Popular semi-supervised learning techniques include self-training, mixture models, co-training and multi-view learning, graph-based methods, and semi-supervised SVM [125] . These paradigms have been increasingly applied to psychiatry studies. For instance, semi-supervised learning has been incorporated into an SVM framework to form a method called heterogeneity through discriminative analysis, which can achieve joint disease subtyping and diagnosis [126] . This approach has shown strength in delineating neurostructural heterogeneity in bipolar and major depressive disorders [127] , schizophrenia [128] , as well as in youth with internalizing symptoms [129] . By unifying autoencoder and supervised classification, an unsupervised autoencoder model was also developed for improved diagnosis of ASD [130] . Additionally, semi-supervised learning has gained increasing mental health applications in digital data from electronic health records (EHRs), social media and mobile phones [131] - [133] . See Section 4 for a detailed discussion.

Although complex supervised learning models often produce better classification or prediction outcomes, their interpretability also decreases with the increasing complexity. We will discuss the interpretable ML methods in more detail later (Section 6). Additionally, the labeled data require the knowledge of the ground truth, which is not always accurate or reliable in the case of mental illnesses. For instance, the skin cancer diagnosis may rely on training samples that have been biopsied and cataloged, leaving no doubt as to whether they are malignant or not; however, there is no equivalent of the biopsy in mental disorder. In contrast, unsupervised learning relaxes the assumption of labeled samples and can be useful for exploratory data analysis. Unsupervised learning models can be either generative or discriminative.

Deep learning describes a collection of methods that use artificial neural networks for various tasks in machine learning. Through a specifically designed deep neural network structure, high-level feature representation can be learned from raw features, which may offer an end-to-end analytic framework for disease analysis and prediction. With the advancement in imaging technologies, an increasing number of large-scale multi-center datasets have been established for building robust ML models to fully explore the informative feature representations from the complex brain and genomic data. By training on large-scale cohorts, deep learning encodes robust informative neuroimaging representations and has been found to outperform standard machine learning in a variety of application scenarios [18] , [136] - [138] .

Deep autoencoder. The deep autoencoder, also known as stacked autoencoder (SAE), aims to learn latent representations of input data through an encoder part and uses these representations to reconstruct output data through a decoder part. By stacking multiple layers of autoencoders, a deep autoencoder model is formed to discover more complicated and potentially nonlinear feature patterns. The deep autoencoder model has been applied to extract lowdimensional features from the amplitude of low-frequency fluctuations in fMRI [139] . Clustering analysis with the latent features uncovered by the deep autoencoder successfully identified two subtypes within major psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder. A deep learning model was also designed based on a sparse stacked autoencoder and applied to lower the dimensionality of fMRI connectivity. The sparsity constraint utilized in this model drove interpretable neural patterns for improved ASD diagnosis [140] . Deep autoencoder has also been applied to implement normative modeling with structural MRI for the quantification of individual abnormalities in neuropsychiatric disorders, including schizophrenia and ASD. The abnormal features extracted using the normative model showed improved diagnosis performance compared with the traditional casecontrol analysis [141] .

Convolutional neural networks (CNNs). Different from conventional multi-layer perception or autoencoder working on inputs of feature vectors, CNNs were designed to better capture the spatial and local structure information from pixels or voxels [104] , [142] . The CNN has been one of the most successful deep learning models applied in various medical applications, due to its strength in exploiting image features and spatial context utilizing neighborhood information to learn hierarchies of features [143] . An EEGbased diagnosis model was established through advanced computational neuroscience methodology coupled with the CNN for accurate detection of major depression disorder (MDD) [70] . This model provided an end-to-end framework to successfully identify translational biomarkers from resting-state EEG in distinguishing depressive patients from healthy people. With whole-brain structure MRI, a 3D CNN model has also been designed to automatically extract multilayer high-dimensional features for the diagnosis of conduct disorder [144] .

Graph neural networks (GNNs). Though deep learning models have shown strength in capturing complex neuroimaging patterns, they are hard to generalize well to non-Euclidean data types, e.g., brain network or genome data. Relying on its non-Euclidean data type, GNNs provide a clever way of learning the deep graph structure and are rapidly becoming state-of-the-art and are leading to enhanced performance in various network neuroscience tasks [145] . For instance, a framework based on graph convolutional networks has been designed for the diagnosis of ASD [72] . By representing the population as a sparse graph to integrate rs-fMRI data as nodal features and phenotypic measures as edges, the designed model showed improved classification performance over state-of-the-art results. An inductive graph neural network model was also devised to embed the graphs containing different properties of task fMRI and drive interpretable connectome biomarkers for improved ASD detection [64] . More recently, a novel graph network model was developed to incorporate dynamic graph computation and 2-hop neighbor nodes feature aggregation into graph convolution for brain network mod-eling [62] . This dynamic GNN demonstrated significantly improved performance in ADHD diagnosis and reveal the circuit-level association between the identified connectomic abnormalities and symptom severity.

Recurrent neural networks (RNNs). As a specific extension of the feed-forward neural network, RNN has the ability in learning features and long-term dependencies from sequential and time-series data. Long-short-term memory (LSTM) model is the most popular RNN and has shown its advantage in capturing temporal dynamic information of neuroimaging data for various psychiatric disorder studies [146] . An LSTM-based RNN architecture was built with the time course of fMRI independent components to exploit the temporal dynamic information and validated to yield an improved diagnosis of schizophrenia [68] . By combining RNN with other deep neural networks, novel machine learning models have also been proposed to model the spatio-temporal dynamics in neuroimaging data. A spatiotemporal CNN model was proposed for 4D modeling of fMRI data with confirmed robustness in identifying the key features in the default mode network [147] . LSTM has also been successfully applied to incorporate multi-stage neuroimaging data into longitudinal analytic frameworks for modeling the trajectories of psychopathology development in various psychiatric disorders. A recent LSTM-based model was built with MEG data to achieve accurate longitudinal tracking of pathological brain states and prediction of clinical outcomes in PTSD [81] .

Generative Adversarial Networks (GANs). GAN belongs to a type of generative model and has gained a lot of attention in computer vision, natural language processing; the method has become increasingly popular for conducting neuroimaging analysis [104] . GAN consists of two competing neural networks (one as generator and the other as discriminator) and can learn deep feature representations without extensively labeled training data. Due to this unique advantage, GAN has been increasingly applied to perform data augmentation for more robust prediction model training with enhanced sample size [148] . Moreover, GAN has been used to impute missing values in multimodal data, a common problem in psychiatry studies, rather than discarding an entire multivariate data point [149] . The adversarial model has also been incorporated into other ML models for specific applications in psychiatry studies. For instance, the discriminative and generative components were incorporated in LSTM to form a multitask learning approach for fMRI-based classification and achieved an improved diagnostic accuracy of ASD compared with the standard LSTM model [150] . By integrating GAN with group ICA, a functional network connectivity-based deep learning model was developed for the diagnosis of major depressive disorder and schizophrenia [151] . The generator with fake connectivity was trained to match the discriminator with real connectivity in the intermediate layers while simultaneously a new objective loss was determined for the generator to improve the diagnosis accuracy.

The strength of deep learning algorithms is that they can implement complex predictor-response mappings, but the power also comes at the cost of requiring a very large sample size to feed a large number of model parameters. This poses some overfitting and result interpretation challenges in psychiatric applications [18] .

Regardless of the ML paradigms in psychiatric applications, there are some common themes that distinguish between automated or human-in-the-loop machine intelligence and human intelligence. In a recently published white paper "Machine intelligence for healthcare", four important features are emphasized for ML systems [152] . These concepts are equally applicable to precision psychiatry [11] .

• Trustworthiness -the ability to access the validity and reliability of an ML-derived output across varying inputs and environments. In other words, psychiatrists need to be able to evaluate the limitations of an ML system and confidently apply system-derived information for psychiatric evaluation. • Explainability -the ability to understand and evaluate the internal mechanism of a machine. The development of ML systems will need to account for data quality, quality metrics for the system's functioning and impact, standards for applications in the environment, and future updates to the system. • Usability -the extent to which an ML system can be used to achieve specified goals with effectiveness, efficiency, and patient satisfaction in multiple environments. These applications need to be scalable across multiple settings while preventing additional burdens on providers and patients. • Transparency and Fairness -the right to know and understand the aspects of an input that could influence outputs (clinical decision support) from the system. Such factors should be available to the people who use, regulate, and are affected by any type of care decision that employs the ML algorithms. The potential bias in the data needs to be identified and informed prior to decision making. The first two features are related to interpretability, which we will discuss in more detail in Section 7. The other two features will be discussed in Section 8.

In this subsection, we provide several ML examples to illustrate the strengths in prediction/classification diagnosis analytics for different mental disorders. These representative case studies cover different data modalities (rs-EEG, task fMRI, and ECoG) using different ML strategies.

Case Study 1: Sparse latent space learning for treatmentpredictive EEG signature quantification in depression. Antidepressants have shown only modest superiority over placebo medications, which is in part because the clinical diagnosis of MDD encompasses biologically heterogeneous conditions that relate differentially to treatment outcomes. There is a robust neurobiological signature for an antidepressantresponsive phenotype that could identify which patients will derive a large benefit from medication. To address the challenge, a sparse EEG latent space regression ("SELSER") model, Wu et al. successfully identified the antidepressant responsive EEG brain signature in major depression (Fig. 3A ) [85] . By jointly learning the spatial mapping and regression weights, this new machine learning tool was able to amplify the signal-to-noise ratio (SNR) and quantify treatment-predictive signatures in a low-dimensional latent space. The identified brain signature yielded significant prediction for the antidepressant outcome (n = 228), which holds promise in benefiting treatment stratification toward the improved clinical outcome. An interpretable cortical pattern was further observed through a source mapping from the scalp spatial pattern, mainly contributed by the right parietal-occipital regions and the lateral prefrontal regions (Fig. 3B) . The validation analysis with an independent cohort showed that treatment outcomes predicted by the brain signature are significantly higher in the partial responder group versus the treatment-resistant group demonstrating its replicability. Case Study 2: Unsupervised learning-based identification of neurophysiological subtypes in psychiatric disorders. The neurobiological heterogeneity has substantial effects on treatment outcome even while often being independent of pretreatment clinical symptoms. For example, although psychotherapy is at present the most effective treatment for PTSD, many patients are nonetheless non-responsive and display differences in brain function relative to responsive patients. With sparse K-means clustering, Zhang et al. [53] developed a data-driven subtyping framework to accom-plish simultaneous feature selection and sample clustering on the high-dimensional power envelope connectivity of rs-EEG source-reconstructed signals. This approach successfully identified two psychiatric subtypes with distinct functional connectivity patterns in PTSD and MDD (n = 648), prominently within the frontoparietal control network and default mode network (Fig. 3C) . Importantly, linear mixed models in an intent-to-treat analysis on symptom severity revealed that the two subtypes differentially responded to psychotherapy and antidepressant versus placebo. A classification analysis based on RVM further confirmed that the EEG connectivity-driven subtypes can be distinguished by rs-fMRI connectivity with a discriminative pattern consistent with the EEG connectivity pattern (Fig. 3D) . The data-driven subtyping framework allows the detection of subpopulations with distinct dysfunctional signatures so that further clinical and mechanistic investigations can be focused on more neurobiologically homogeneous subtypes.

Case Study 3: Classification of anxious vs. non-anxious brains from fear extinction learning task-based fMRI. Using a neuroimaging cohort study (n = 304 adults, 92 anxiety patients, 74 trauma-exposed individuals, 138 matched controls), Wen et al. [153] examined how the fMRI activations of 10 brain regions that were commonly activated during fear conditioning and extinction (Fig. 4A ) might distinguish anxious or trauma-exposed brains from controls. They proposed a CNN classifier (Fig. 4B ) to map the fear-induced fMRI activities in space and time to a prediction probability score indicating that the subject belongs to the anxious (or trauma) group. The CNN achieved an AUC of 0.84 ± 0.01, 0.75 ± 0.03 sensitivity, and 0.77 ± 0.02 specificity in 5-fold cross-validation (Fig. 4C) , outperforming other ML methods (e.g., SVM, random forest). The prediction score was predictive of the anxiety sensitivity index (ASI) in the control group (Fig. 4D ). Three different specificity analyses were conducted to examine the specificity of the fear network in discrimination. First, the activations of ten brain regions were randomly selected from the whole brain for classification. Second, 10 regions from the somatomotor network were randomly selected for classification (Fig. 4E) . Third, N (1 N 9) brain regions from the fear network were replaced with N randomly selected brain regions outside of the fear network.

Case Study 4: Decoding mood state from multi-site intracranial brain activity. From intracranial ECoG signals and simultaneously collected self-reported mood state measurements over multiple days in 7 epilepsy patients, Sani et al. [35] developed a dynamic state-space model (SSM) framework to track the patients' mood state variations over time (Fig. 5A) . The modeling framework consists of unsupervised and supervised learning components (Fig. 5B) . The spectrospatial features were extracted from the mood-predictive networks within the limbic brain region. The neural decoders were also highly predictive of the immediate mood scaler (IMS) points at the population level. Furthermore, the same trained decoder could be used for mood state prediction across hours and days, and generalized across a wide range of IMS. In cross-validation, the decoders could predict IMS variations that covered 73% and 33 ± 7.2% of the total possible IMS range across 7 subjects and within individuals, respectively (Fig. 5C ). These results suggest that ML-based decoders can predict mood state variations from neural activity across multiple days of recordings in patients.

The ML technologies can be applied to a wide range of digital platforms, including software (e.g., mobile apps), hardware (e.g., wearable devices, robots), social services (e.g., online chatbots) and clinical practice (e.g., EHRs). In this section, we will review various ML-powered technologies in the non-neuroimaging domains and discuss their applications for precision psychiatry. We will highlight the emerging digital platforms and their underlying ML technologies.

A recent McKinsey study showed that use of telehealth has increased by 38-fold as compared to the pre-COVID baseline [154] . With a steep increase in teletherapy demand and consumption, many companies (such as Talkspace and Headspace Health) provide chat conversations with licensed mental health professionals, the definition of teletherapy has expanded to include these newer modalities of care delivery. These advances in care delivery have enabled collecting massive amounts of text, audio and video data on a routine basis, which was previously only done in controlled research settings. Furthermore, the recent advancements of natural language, speech, and video analysis technologies, combined with the ML tools, have made the field ripe for innovation. The global psychiatrist community is increasingly aware of these developments. For example, a recent survey among more than 700 psychiatrists showed that 49% believed that in the next 5-10 years, ML technology will be able to help analyze patient information to establish prognosis and 54% believed that is likely that this technology can help synthesize patient information to reach a diagnosis [9] .

ML can be applied across all stages of a patient's journey [155] , [156] : risk assessment, diagnosis, prognosis, treatment, and remission in a variety of disorders, including: depression, anxiety, schizophrenia, PTSD, and so on [157] to various sources of data [14] , [158] including: natural language, speech, facial expressions, body language, social media, as well as traditional clinical surveys and neuroimaging results. Table 3 summarizes key recent studies that use ML to support various stages of patient journey. Applying ML makes it possible to build models that are optimized for each patient [5] , as opposed to using traditional statistical models that optimize for group effects. While building ML models, data for representative patients can be used as held-out validation or test sets. Furthermore, given the inter and intra-disease variability between clinical diagnosis and symptoms, ML can be used to model the differential diagnosis between disease categories using methods like multi-task learning. All of these ways of ML applications can be considered to be the first level of precision added to ML-powered psychiatry.

The amount of precision that can be modeled using ML goes beyond this [159] , [160] . During psychiatric evaluation, psychiatrists are trying to build a mental model of what is going on in the patient's life in about 30 minutes. They are trying to understand as much as possible about the patient's history in a very short time and define what "normal" looks like for the patient and identify deviations from that normal. This is done by asking questions to the patient and examining their speech, body language, and their behavioral responses. It is very challenging and almost unrealistic to expect psychiatrists to build an accurate baseline model of the patient's entire life in such a short time span whilst interacting with the patient who is in a compromised psychological state. ML can have a great impact here by building baseline models specific to each patient before their visit and present the bounds for various observations as a reference to psychiatrists during the exam [161] . This is the second level of precision in psychiatry that can be made possible by ML (Fig. 6A) . Take MDD as an example, Figure 6B shows how ML can be applied at different stages of a patient's journey. Similar applications have also been developed in studies of other disorders.

In the following subsections, we describe how ML technologies can be applied to clinically relevant data (e.g., speech, body language, natural language, activity, online behaviors, etc) and to support one or more stages of the patient's journey.

With the development of smart phones, smart watches and other wearable sensing devices, technologies have enabled us to access more information of our physical and mental health than ever [178] . Specifically, several types of signals are relevant for mental health monitoring or assessment (Fig. 7A ):

• Behavioral and physical signals: location (e.g., GPS coordinates), mobility (e.g., accelerometer) • Multimedia signals: face expression, speech patterns • Social signals: social interactions (e.g., call and text message logs), communication patterns, engagement, online gaming • Physiological signals: skin conductance, hear rate variability (HRV), eye movement, electrodermal activity (EDA) • Sleep activity: phone on/off status, sleep duration, sleep staging

These signals have different implications and relevance to mental illnesses. Although none of single signals is indicative of mental disorders, combination of these physical/physiological/social cues may reveal important clues of individual mental health (as compared to the control of his or her own). In the subsequent subsections, we will focus on the analysis of multimedia, language, and social media data and on their mental health applications.

Bringing awareness about a disorder by monitoring symptoms.

Clinically valid determination of a disorder.

Likely progression of a disorder.

Iterative interventions for controlling a disorder. Language -answers to personal questions Diagnosis LSTM fine-tuned w/ health forum data 2425 subjects [168] Language -Facebook posts Risk assessment Logistic regression 68 patients [169] Audio, video -clinical interviews Diagnosis Transformer + multimodal fusion 56 subjects Bipolar spectrum [170] Audio -verbal fluency tasks Remission SVM 56 subjects [171] Sensor -GPS Diagnosis Linear regression 36 subjects PTSD [172] Audio -clinical interviews Diagnosis Random forest 43 veterans [173] Audio, video, skin conductance Remission SVM 110 subjects Schizophrenia spectrum [174] Audio -clinical interviews Diagnosis SVM 70 subjects [175] Video -neutral open-ended questions Diagnosis Logistic regression 16 subjects [176] Language -internet search queries Remission Random forest 23 subjects [177] Audio, video -clinical interviews Diagnosis Gradient boosting 17 subjects

Voice and visual (video of facial expressions and body language behaviors) data have recently gained increasing attention in the studies of mental disorders. ML technologies using speech samples obtained in the clinic or remotely may help identify biomarkers to improve diagnosis and treatment. In the early stage of practice, psychologists have already used auditory and visual cues to assist the mental illness diagnosis [179] . Among all the types of data that may carry biomarkers for mental illness, speech and video are not only the readily available in traditional teletherapy settings but also the most interpretable as the most natural form of human communication.

Audio and speech features. Features derived from audio data (acoustic features) have been found to be relevant in many mental health disorders [172] , [180] , with depression, bipolar, and schizophrenia being the most commonly studied disorders with regards to speech analysis. Table 4 lists some commonly used acoustic feature categories in the anal-ysis of mental illnesses [181] . These categories have enabled standardization and ease of interpretation of ML methods applied on speech data, which is the key for making ML methods useful for clinical applications.

Models built from speech-based features, have been particularly effective in predicting the diagnosis of depression and suicidality [182] . Modeling approaches for depression include predicting the presence, severity, or score with varying levels of success [162] , [170] . These models use prosodic, spectral or other features computed from raw speech data to quantify flattered speech, slow speech and other relevant markers. The target outcome variable is derived from a clinically valid scale such as a patient health questionnaire (PHQ-9). Furthermore, models for suicidality have explored similar features and have been used in multi-class settings to differentiate between healthy, depressed, and suicidal speech.

One key challenge in applying speech-based models in clinical practice is the lack of longitudinal validation of data acquired in real-world settings. However, this issue is beginning to get addressed in studies like [183] , which detect manic and depressive speech from recordings of outgoing speech from phone conversations of consenting participants. Another key challenge remains is the lack of large labeled datasets for evaluating performance across various methods. To this end, it is encouraging to note that recent efforts backed by companies like Ellipsis Health [163] , [184] , have used deep learning and transfer learning to predict depression and anxiety scores with a high performance based on a large labelled dataset of over 10,000 unique speakers. Some commercial applications claim to have human-level accuracy in detecting depression using only 20-30 seconds of audio clip [185] , [186] .

Visual features. Although body language and facial expressions form a key part of a psychiatric exam, ML has only recently been applied to analyze such data objectively. To date, most work has been targeted to support the care for suicidal ideation [187] and depression [165] , [166] , [188] , with few studies also dedicated to schizophrenia [175] and autism spectrum disorders [189] . Features derived from video data have been found to be relevant across all of these disorders. These features can be roughly categorized into features derived from overall facial expression, eyes, gait, and posture (Table 4) .

Studies in suicidal ideation have mainly focused on using interpretable ML for characterizing the disorder. This makes the ML models more applicable in augmenting human caregivers by bringing up specific insight that they'd like to measure. The approaches to depression have been mixed between work focused on using deep learning for predicting the depression score and those using predefined features in an interpretable model. Some approaches [190] have also involved fusion of video features derived from each frame that are used to train a sequential deep network and most have used pre-training to account for the relatively small size of depression datasets [191] . While these models perform very well on the same held-out test set, their clinical application remains limited due to a lack of interpretability. To improve the interpretability, few researchers have acknowledged this and built depression activation maps to highlight the facial areas corresponding to depression severity as learned by the model [192] ; however, using predefined features has been most successful in providing interpretable results [191] , [193] .

NLP allows computers to analyze, understand, and derive meaning from text and speech similarly to how humans do. NLP is opening up new possibilities for how mental health professionals can evaluate patterns in language to help identify and predict psychiatric illness in patients (Table 4). Language being one of the primary expressions of human behavior carries a variety of implicit and explicit markers relevant to mental health [194] , [195] . Language is also more abundantly available compared to speech. For example, social media platforms contain a large quantity of real-world language data, whereas the matched scale of speech data is limited. There are two sorts of NLP applications for detection of specific mental health symptoms. The first type of applications is directly applied to patients: speech and language are the important information sources used to diagnose mental disorders, varying from predicting the risk of suicide and early psychiatric readmission to identifying phenotypes and comorbidities. The second type of applications is indirectly applied to EHR and clinical records (tests, transcripts), which can be used for automating chart reviews, clustering patients into phenotype subtypes, predicting patient-specific outcomes. EHRs (including pathology reports, lab results, clinical tests and clinical session transcripts) are systematic collections of longitudinal, patient-centered clinical records. Patients' EHRs consist of both structured and unstructured data: the structured data include information about a patient's [196] . The EHR language is at least one level abstracted from the symptoms expressed directly by a patient since it consists of notes taken by a clinician. However, the unique advantage of EHR data is the ease with which demographic and socioeconomic features can be combined with language data. Symptoms derived from the free text in EHR data can be used to predict a diagnosis for disorders like bipolar [197] and symptoms like situational aggression [198] as well as suicidal ideation [199] with performance comparable to clinicians. Furthermore, discharge summaries from EHRs have also been used to predict remission [200] . Aside from symptoms, a variety of relevant mental health data such as intervention status and physical health comorbidities can be routinely extracted from EHRs using NLP methods to enhance outcomes research [201] . Privacy concerns around sharing EHR data remain one of the key challenges in validating generalization of NLP methods. Encouragingly, there has been growing interests in using transformers for generating artificial mental health clinical notes to mitigate this issue [201] , [202] .

The advances in text-based mental health interventions (e.g., Talkspace and CrisisTextLine) have made transcripts of clinical sessions easily amenable via NLP. Aside from developing models for detecting suicide ideation [203] , NLP can also be applied to these datasets to understand populationlevel trends, such as the increase in anxiety and decrease in quality of personal relationships during the COVID-19 pandemic [204] . Since language data are ubiquitous, one of the challenges in applying NLP for advancing mental health is standardizing data sources. Depending on the task, different types of data may yield different levels of "signal". For example, for predicting first episode psychosis, language data from clinical tests has higher performance compared to transcripts of free speech [205] . On the other hand, data collected "free-speech" samples for diagnostic purposes has been found to be highly effective in developing a language-based depression screening that generalizes well across various age groups [167] , [184] , [206] .

Social media companies collect a wide variety and a large amount of language data which contains clinically-relevant information ( Table 5 ). While this information can also be extracted on a population level, such as the notable rise in cognitive distortions over time [207] , the same information can be attributed on an individual level [208] , making social media a powerful tool to support mental health risk assessment and diagnosis. Language from Facebook posts, for example, has been shown to contain markers for depression such as rumination and sadness can be detected in the data up to 6 months prior to a clinical diagnosis at hospital [168] . Models applied to Facebook and other social platforms like Twitter, Reddit and so on have been successful in predicting diagnosis of other disorders like psychosis, anorexia, anxiety, and stress levels [209] - [211] . Aside from language present in user posts and comments, these models also include processing media data such as Instagram images [212] , or combining images and text [212] , [213] . It is important to note that online search forms an equally compelling dataset that can be used alongside social media activity to enhance overall performance.

Recent developments of transformer models, including those learning multilingual language representations, have enabled researchers to build NLP models that can generalize across languages and apply them to social media data, for example, to detect depression or self-harm [214] , [215] . Furthermore, specialized language representations that were trained on mental health specific conversations and are made publicly available [216] , have been shown to improve performance compared to non-specific representations. Finally, the use of transformer embedding can be applied to pre-identified sections in language which correspond to responses to standard clinical assessments such as the subjective well-being scales [217] , supporting the high-accuracy prediction of the standard survey scale responses without directly running the survey.

While social media solves the scale issue with millions of samples available, one of the key challenges for social media data is the lack of clinically-valid labels [218] . Most work has relied on using self-disclosure of mental illness as the labels, which tend to be noisy and bring the additional problem of defining a healthy control. Despite the challenges, the validity of social media data to support mental health diagnosis and risk assessment has been repeatedly proven.

Smartphones, wearables and other connected devices equipped with ambient sensors (Fig. 7B ) are increasingly capable of recording physiological measurements like motion and location sensing, heart rate, and galvanic skin response that are known to affect mental health [219] . In addition, some of the less obvious measurements (such as keystroke usage patterns) have also been shown to be implicated by mental illness [220] , [221] . Additionally, online gaming behaviors, such as interaction patterns with nonplayer characters (NPCs) and other game behavior patterns, can be used to measure cognitive performance and their relationship with mental illness [222] , [223] . These measurements from mobile sensors ( Table 6 ) form some of the most widely available sources of mental health data, and can be useful at various levels of granularity-from raw sensor data (e.g., the accelerometer) to derived highlevel features (such as psychomotor activity). This has inspired big corporations like Apple Inc. to invest in detecting depression and cognitive decline using data collected from their wearable devices [224] . Sensor-based measurements are found to be correlated with high-stress levels and a variety of ailments including depression, anxiety, psychosis, and bipolar disorder [225] , [226] . Since sensor-based data are widespread and readily available, these data offer an opportunity to build baseline models for individual users; these baseline models can be used to identify significant physiological changes in users and possibly inform clinical interventions. [230] Language Depression, Anxiety Mindstrong [220] Keystrokes Serious mental illness Sonde Health [164] Voice Mental fitness Ellipsis Health [163] Voice Stress Amazon Halo [231] Voice Emotion detection Apple Watch [186] Mobility, Sleep Depression Alphabet Fitbit [232] Skin conductance Stress Kintsugi [233] Voice Depression, Anxiety Bewie [227] Raw data from smartphone Multiple MindDoc

Language (ask daily question) Depression Clarigent Health Voice Suicide risk

Using data from mobile devices, digital phenotyping is collected in real-time and targets specific individuals. Devices that collect data streams from patients, such as surveys, cognitive tests, social medial interactions, GPS coordinates, and behavioral patterns (e.g., keyboard typing), have great potentials for monitoring, managing and predicting the individual's mental health [227] , [228] . Overall, continuous quantification of these data streams may result in clinically useful markers that can be used to refine diagnostic processes, tailor treatment choices, improve condition monitoring for actionable outcomes (such as early signs of relapse), and develop new intervention models [229] .

While research studies have demonstrated promising results in using ML to support the patient's journey in mental health, the applicability in clinical practice has been limited. Table 7 lists examples of platforms and services that use ML for mental health. While most platforms focus on developing a risk assessment using single modality such as voice, the initial commercial viability of these platforms is promising for the success of using ML in mental health since they enable collection of large amounts of data which can be used in further development of biomarkers with applications in clinical practice.

Many areas of mental health technology development aim to scale approaches that are applied in clinical research or practice today. For example, there are between 10,000 to 20,000 smartphone apps that digitize mindfulness or cognitive behavioral therapy techniques [234] , allowing the user to engage in psychotherapy on their own at a greatly reduced price compared to in-person therapy. Like the apps in this example, the quality is highly variable and the mechanisms used to validate them is often dubious. Finally, since this area is relatively new, the industry and governmental standards to validate such a technology are still developing. We will briefly outline two interrelated areas of development: digital measurements and digital interventions.

Digital measurement applications. We are entering a new era of digital psychiatry [8] , [235] . In 2016, the Harvard professor Jukka-Pekka Onnela coined the term digital phenotype [236] , which refers to the use of mobile devices and other digital data sources to measure behavior and physiology that is relevant to understand underlying brain activity that is relevant to pathological states. These techniques utilize measurement paradigms from translational neuroscience that were developed in laboratory settings such as direct quantification of motor (i.e. movement, muscle activation) and physiological activity (i.e. heart rate, electrodermal response) more than traditional clinical scales or self-report scales. The advantage of this approach is that it better aligns with emerging knowledge of rapid-acting biological processes and provided high measurement accuracy through direct rapid sampling rather than broad clinical measures that are taken sporadically and measure a broad set of mental and behavioral states over a long measurement period [237] - [239] .These measurement approaches have relevance in every area where measurement is of relevance including treatment development, treatment selection, and ongoing monitoring.

Medications that target mental health conditions have a significant history of failure. Most psychiatric medications were discovered capriciously rather than being developed based on knowledge of the underlying biological mechanisms. As new medications emerge from basic and translational neuroscience research, both drug developers and clinicians struggle with how to measure the effects of new treatments and how to properly target old treatments. For example, traditional antidepressant medications are designed to slowly titrate serotonin levels, resulting in slow global effects over a 2-4 week period. Correspondingly, measures of depression based on the DSM, query about the presence of depressive states over a 2-week period. New classes of anti-depressant such as ketamine and psilocybinpsylocibin affect specific depressive symptoms in minutes. Further, the mechanistic effects, and thus the need for measurement, is much more specific and granular. In fact, most classes of anti-depressants including serotonin reuptake inhibitors (SSRI) and psilocybinpsylocibin, and ketamine, act on serotonin receptors which ultimately impact peripheral motor and physiological activity [240] , [241] . Serotonin regulation will likely have a direct effect on depression symptoms such as psychomotor retardation, but minimal direct effects on feelings of guilt. As such, methods used to directly measure motor output have a higher likelihood of capturing both pathology and treatment effects.

As an example, research effort has been dedicated to using computer vision and voice to directly quantify motor activity. Some recent work has demonstrated that digital phenotyping parameters that reflect gross motor activity including speech characteristics (rate of speech, tone) and facial/head movements are associated with suicidal risk [242] , SSRI response in major depressive disorder [243] , negative symptomatology in schizophrenia [244] , and Parkinsonian tremor [245] . Such approaches are now being commercialized for all phases of drug development from proof-ofconcept to direct measurement to make decisions about ongoing treatment needs. Such measures solve many of the current problems in clinical measurement since they can be captured remotely in an automated way. These measures can also be captured at a much higher frequency and can provide a sensitive numeric value.

These new approaches to measurement are not without significant challenges. First, methods that are adapted from the laboratory often lack the tight experimental control necessary to interpret the data correctly. For example, a rapid increase in physiology can indicate stress, but also exercise or other forms of exertion. Second, while the scientific basis of these measurement paradigms may be sound, commercial approaches are rarely validated to the extent required to be of clinical utility and rarely sufficiently transparent in their approach to be used for regulatory approval.

Digital interventions. The other rapidly emerging area of mental health technology are digital approaches to clinical care. We will briefly outline some of the leading approaches. Importantly, digital approaches to clinical care are often aligned with a digital measurement approach as these approaches are "blind" without some sort of remote data. A number of companies such as Mindstrong Health [220] , IesoTrigger Health [246] , and Headspace Health [247] , [248] , have attempted to integrate digital phenotyping of some kind to identify when patients are in acute clinical need. However, it is unclear how accurate these methods are as they are typically unpublished. This work has led to development of models that identify patterns in patient language and clinician language that are markers of improved outcomes [249] , which can be used to measure success of various therapy modalities, treatment design, as well as to improve care quality [250] .

Digital therapeutics is generally referred to the use of mobile devices to offer automated cognitive behavioral therapy (CBT), mindfulness, or other validated psychotherapy approaches in an automated fashion. These app-based approaches undergo the same clinical validation process and traditional medications and are often developed in collaboration with large drug developers. Examples that are in development or have received FDA (Food and Drug Administration) approval include treatments for substance use disorder, ADHD, schizophrenia, autism, MDD, PTSD, and generalized anxiety disorder [251] While digital therapeutics attempt to scale treatment, telehealth aims to scale the treatment provider network. Mental health is an area of treatment where there are many effective treatments but little access to treatment providers [252] . The issue of access became most acute during the emergence of COVID-19 when significant wide-spread mental health needs emerged along with greatly decreased access to care. To address this need, a large array of options have emerged, many reinforced by the emergency COVID-19 Telehealth Act of 2021 that allowed for remote patient care [253] . These services, which are accessible directly to consumers, or more often, provided by a third-party payer, provide access to coaches and clinicians via different mobile platforms including text, voice, and video communication. Services vary from mental health coaching provided by lay-professionals to psychiatric and psychological services. While still in their infancy, early evidence has shown that telehealth services can perform at parity with traditional in person therapy [254] . Therefore, teletherapy is likely to be a dominant form of mental health treatment in the future.

A central goal of precision psychiatry is to integrate all clinical, physiological, neuroimaging and behavioral data to derive reliable individualized diagnosis. Importantly, the health-related data are produced daily, especially those from personal devices. The most essential effort in multimodal data analysis tasks is exploratory: to explore the relationship between modalities, complementarity, shared versus modality-specific information and other mutual properties. Multimodal data fusion techniques present a framework to infer information how different data modalities interact and inform each other, are used in medical diagnosis [45] , [255] , [256] . In this section, we will review several data fusion methods in diagnostic analytics (Section 5.1). We will focus on multimodal neuroimaging data (Section 5.2), and then extend the discussion to other modalities that include vocal and visual expression data (Section 5.3).

In the past decades, numerous research efforts have been dedicated to developing powerful ML methods for multimodal data fusion [45] , [257] - [260] . Some commonly used approaches are summarized below.

Multivariate Correlation Analysis. Canonical correlation analysis (CCA), as a standard statistical method based on second-order statistics for data fusion, aims at finding a pair of linear transformations to drive latent variables (aka. canonical variates) that have maximized correlation between two different data modalities [261] . For a more general setting, multiset/multiway CCA (mCCA) has been developed as an extension of the standard CCA to multimodal fusion by maximizing the overall correlation among latent variables from more than two sets of modalities [45] , [262] . Similar to CCA, partial least squares (PLS) and its extensions, i.e., multiway PLS (N-PLS), provide alternative approaches to integrate multimodal data by maximizing the covariance between latent variables from different modalities [263] , [264] .

Matrix and Tensor Factorization. Based on matrix and tensor factorization techniques, joint blind source separation (BSS) approaches have been developed and successfully applied to multimodal fusion of biomedical data [258] , [265] . As a typical example, joint independent component analysis (jICA) aims to maximize the independence among jointly estimated components from multiple modalities that are assumed to share the same mixing matrix [266] . The jICA approach involves concatenating modality features alongside each other and then performing ICA on the composite feature matrix [267] . Independent vector analysis (IVA) is another extension of ICA to multiple datasets, which makes use of dependence across datasets by defining source component vectors concatenating a specific source estimated from multiple modalities [257] , [258] . Coupled matrix and tensor factorization (CMTF) was developed to simultaneously factorize multiple datasets in the form of matrices and high-orders tensors using tensor decomposition [268] , showing strength in capturing the potential multilinear structure for multimodal fusion. Besides extracting shared common components, some multimodal fusion tasks are also interested in deriving individual components that are modality-specific. Common and individual feature analysis (CIFA) [269] and joint and individual variation explained (JIVE) [270] models have been proposed to achieve this goal. By jointly decomposing multiple feature matrices, CIFA and JIVE are able to simultaneously estimate common and individual feature subspaces. A further extension of CIFA has been achieved by leveraging high-order tensor factorization [265] , which provides an efficient way to perform a multidimensional fusion of multiple data modalities. Multi-Kernel Learning. Multi-kernel learning (MKL) has won many successful applications in multimodal data fusion due to the full utilization of multiple kernels that enable simultaneous learning from various modalities with heterogeneous data [271] , [272] . Different kernels naturally correspond to different modalities, such as neuroimaging, clinical, behavior, speech features, etc., which may provide complementary information to drive improved modal learning performance. The MKL problem can be set as a linear combination of kernel matrices or a nonlinear function with specified forms of regularization. MKL may be designed under different ML models including SVM, Gaussian process, and clustering. Among them, MKL-SVM has been most popularly applied to integrate heterogeneous data modalities in studies of mental health [273] - [275] .

Deep Learning-based Fusion. Empowered by cuttingedge deep learning techniques, emerging methods have been increasingly developed for deep multimodal fusion [276] . Deep learning-based fusion allows integrating multiple modalities based on learned high-level feature representations that are theoretically more comparable to each other and more informative for predicting the targets [277] . By exploiting cross-modal manifolds as a feature graph, a deep manifold-regularized learning model was recently designed to achieve improved phenotype prediction by integrating transcriptomics and electrophysiology data from neuronal cells [278] . Graph neural networks show capability in information fusion for multimodal causability by defining casual links between features with graph structures, thereby enhancing the explainability of the derived multimodal feature representation [279] . By extending graph neural networks to multimodal structures, deep representation approaches have also been designed for integrating brain networks constructed from diverse modalities [280] - [282] .

Neuroimaging data types are intrinsically dissimilar in nature, having different spatial and temporal resolution [259] . Instead of entering the entire data sets into a combined analysis, an alternate approach is to reduce each modality to low-dimensional (latent) features of selected brain activity or structure and then explore associations across these feature sets through variations across individuals. Exploiting such latent feature representations from multiple neuroimaging modalities for diagnosis has generally shown to improve performance compared to using a single modality alone [283] . Multimodal fusion allows for the integration of neuroimaging data modalities from different scales of spatial and temporal resolutions and offers an elegant way to exploit complementary information for more accurate and robust characterization of brain dysfunctions. Therefore, multimodal learning mechanisms that take advantage of multimodal data sources are instrumental in optimal decisions for diagnosis, treatment, prognosis, and planning in many applications in medicine.

A combination of mCCA and jICA was successfully applied to fMRI and DTI fusion in the diagnosis of schizophrenia and bipolar disorder [284] . CMTF has been applied to identify diagnostic biomarkers of schizophrenia by integrating sMRI, fMRI, and EEG [285] . MKL-SVM has been successfully applied to integrate multimodal structural neuroimaging for predicting differential diagnosis between bipolar and unipolar depression [286] and to combine sMRI and fMRI for improved classification of trauma survivors with and without PTSD [287] . More recently, it also showed efficacy in the diagnosis of early adolescent ADHD by integrating sMRI, fMRI, and DTI [288] . In learning low dimensional representations of functional and structural MRI [289] , the functional MRI can be split into several independent component networks, each treated as a separate modality along with the structural scan for learning using autoencoders. Furthermore, MKL methods have been used for diagnosing schizophrenia by combining markers from MRI and DTI [290] . A multimodal graph convolutional network was designed to integrate functional and structural connectomics data for an improved prediction of phenotypic characterizations in ASD [280] . By combining multiple typical neural network structures, multimodal deep learning models have also been developed to effectively integrate fMRI connectivity and sMRI features [291] , and also genomic data [292] for discovering schizophreniaassociated brain dysfunction. Methods for learning joint representations from neuroimaging and non-neuroimaging data are still in early development [293] and there is an opportunity for ML methods to evolve for this task. For example, transformer networks with late fusion can be used to learn joint representations from various modalities such as EEG and facial video data [294] .

Multimodal approaches consist of combining data from various sources to jointly arrive at an answer. Given how little is conclusively known about which type of data, neuroimaging, social media, speech, video, sensor data carries the most phenotypes for mental illness, it only makes sense to combine the information from these data sources. In addition, this also enables modeling the inter-dependencies between these data which may not be observable by a human expert at the same time. For example, many features listed in Table 4 are known to be relevant in depression; however, observing them simultaneously can be very challenging for a clinician. MKL and multi-task learning methods have been used to jointly learn from sensor and smartphone usage data to predict subjective well-being [295] . The success of transformer networks in jointly modeling video, speech, and language data has catalyzed multimodal modeling in mental health [296] . Multimodal modeling techniques can also be used in modeling symptoms such as emotion dysregulation [297] , loneliness [298] and sentiment analysis [299] . In a prognostic study, an SVM-based multimodal ML approach was developed to integrate clinical, neurocognitive, neuroimaging, and genetic information to predict psychosis in patients with clinical high-risk states [76] . Deep autoencoder-based fusion approaches have been designed to integrate dynamics of facial and head movement and vocalization, and successfully applied to the prediction of depression severity [300] .

Molecular phenotyping is referred to as the technique of quantifying pathway reporter genes (i.e. pre-selected genes that are modulated specifically by metabolic and signaling pathways) in order to infer activity of these pathways. Mapping genes and genomics to behaviors can identify risk factors and biomarkers in mental disorders. The brain is the central organ exposed to stressors and external behavioral interventions, and therefore is a vulnerable organ subject to changes in multiple interacting biological networks at the systems level. ML methods have been contributing enormously to capturing the complexities of interacting variables within and across multiple levels (Fig. 9A )-particularly at the molecular level -for identifying mechanisticbased phenotyping models as new targets for the prevention and treatment of mood and cognitive disorders. The advent of unbiased next-generation sequencing (NGS) prompted the development of advanced bioinformatics and ML tools to profile and decode large molecular datasets (e.g.: transcriptomics, epigenomics, metabolomics) at the genomewide level in health and disease states (Fig. 9B ). To date, there is increasing recognition of the utility of ML methods to integrate these multi-level molecular datasets with clinical characteristics to map specific neurobiological substrates into the complexity of symptom clusters, which may aid the classification of diseases, prediction of treatment outcomes, and selection of personalized treatment. Emerging avenues in molecular neuroscience and computational psychiatry for new mechanistic models for the prevention and treatment of CNS disorders.

Animal models has been playing a vital role towards precision psychiatry in understanding mechanisms of diseases and predicting treatment responses [301] , [302] . To bridge the scientific knowledge gap from animals to humans, gene expression studies offer an example of how integrating basic neuroscience, ML, and bioinformatics approaches can contribute to advancing understanding of the molecular basis of MDD. Using RNA sequencing (RNA-seq) assays and gene coexpression network analyses (based on hierarchical clustering to identify gene modules), differential gene expression profiles have been shown across six key brain regions, such as the ventromedial prefrontal cortex (PFC) and dorsolateral PFC among others, in post-mortem tissues of subjects suffering from MDD as compared to age and sex-matched controls with remarkable sex differences in these molecular pathways [303] . Recent work using RNAseq assays at single nucleus resolution (snRNA-seq) and tdistributed stochastic neighbor (t-SNE) embedding analyses showed cell-type specific transcriptomic profiles in the postmortem dorsolateral PFC that are differentially regulated in MDD cases as compared to respective controls, with the greatest gene expression changes in deep layer excitatory neurons and immature oligodendrocyte precursor cells [304] . Importantly, these gene expression studies in humans were supported by findings in rodents showing a brain that continually changes with experience [305] . Several groups using RNA-seq assays and bioinformatic analyses showed striking transcriptomic differences in the ventral and dorsal hippocampus in the responses to stress-a primary risk factor for multiple psychiatric diseases-with the ventral hippocampus being particularly sensitive not only to the effects of stress [306] but also a target for the responses to next-generation antidepressants [307] , [308] .

The expansion of NGS to single-cell resolution assays requires more advanced bioinformatics analyses, which utilize ML to analyze these large datasets, including denoising and dimensionality reduction, cell-type classification, gene regulatory network inference, and multimodal data integration [309] , [310] . Bioinformatic approaches, such as Seurat, combine unsupervised nonlinear dimensionality reduction, K-nearest neighbor graph analysis for cell-type clustering, and weighted nearest neighbor analysis for multimodal data integration [311] . Deep learning approaches, such as the autoencoder, provide another example of tools used for denoising and dimensionality reduction with computational scalability [312] - [314] . Autoencoders can also be used in a supervised manner for transfer learning across datasets, e.g., to learn the embedding from a larger, already annotated dataset and transfer this knowledge to cluster new datasets [315] . The combination of multimodal data generated from the simultaneous assessment of transcriptomic profiles with regulatory landscape or spatial location in the same single cell [316] - [319] will allow a deeper molecular characterization of discrete cellular states [311] .

Integrating multidimensional factors for new mechanistic treatment models. It has been increasingly recognized that mood and cognitive disorders are unlikely to be only brain-based diseases. Additionally, growing evidence suggest that they are system-level disorders affecting multiple interacting biological pathways [320] , involving the dynamic cross-talk between the brain and the body. Using hierarchical clustering to integrate in-vivo molecular measures of brain metabolism with clinical symptoms in MDD patients, recent work showed that, at least in these cases, the specific neurobiological substrates map into discrete clinical symptoms, including anhedonia [321] . Furthermore, the integration of multidimensional factors spanning mitochondrial metabolism, cellular aging, metabolic function, and childhood trauma has been shown to provide more detailed signatures to predict longitudinal changes in depression severity in response to the metabolic agents used as antidepressant treatment than individual factors [322] . Use of multi-omics approaches and random forest classifier has been shown to achieve 85% sensitivity and 77% specificity in prediction of the PTSD status. This system-level diagnostic panel of multiple molecular and physiological measures outperformed separate panels composed of each individual data type, with certain mitochondrial metabolites among the most important predictors [323] , [324] .

An additional ML application example include the integration of multidimensional phenotypic measures to identify those mechanisms that predispose apparently healthy individuals to develop maladaptive coping strategies from those that confer resilience. Using a high-throughput unbiased automated phenotyping platform that collects more than 2000 behavioral features and supervised ML that minimizes Bayesian misclassification probability, recent work showed that a rich set of behavioral alterations distinguish susceptible versus resilient phenotypes after exposure to social defeat stress (SDS) in rodents [325] , [326] . At the individual level, a ML classifier integrated a priori constructs, including measures of anxiety and immune system function, predicted if a given animal developed SDS-induced social withdrawal, or remained resilient, with 80% sensitivity, which is better than the categorization power based on either individual measure alone [327] .

To develop personalized psychiatry strategies for better diagnosing and treating mental disorders, it is essential to meet the demand for ML enforced by the recent advent of molecular biology protocols that opened up the opportunity to capture central nervous system nanovesicles (known as exosomes) for examining specific neurobiological substrates, including transcriptomic profiles, dynamically and temporally in vivo. The development of advanced ML methods for dynamic network analyses will permit to link brain molecular targets and signaling pathways with other levels of analyses (e.g., functional connectivity) in vivo and to in-corporate complex relationships between the brain and the rest of the body to redefine thinking about the modifiable mechanisms throughout the complex clinical disease course.

Explainable Artificial Intelligence (XAI) aims to provide strong predictive values along with a mechanistic understanding of AI by combining ML techniques with effective explanatory techniques and make it easily understood by the end users. XAI has found emergent applications in medicine, finance, economy, security, and defense [328] , [329] . In psychiatry, the mission of XAI is to help clarify the link between neural circuits to behavior, and to improve our understanding of therapeutic strategies to enhance cognitive, affective, and social functions [330] , [331] . Notably, XAI distinguishes the standard AI in two important ways: (i) promote transparency, interpretability, and generalizability; (ii) transform classical "black box" ML models into "glass box" models, while achieving similar or improved performance. From the diagnosis or prognosis perspective, it is crucial to know whether the ML solutions can be explainable to the point of providing hidden mechanistic insights, such as how does the brain accomplish a particular function or a set of complex behaviors. For instance, a classification function learned by the machine to predict a disease outcome would not only need to report a probability outcome but also need to address additional questions for the end-user: why is this outcome instead of the alternative? How reliable is the outcome? When does it fail if something is missing or misrepresented? When and why the prediction is wrong? Accordingly, a model with improved interpretability comes with parameter/structure/connectivity constraints and some prior domain knowledge. The models can be continuously adapted such that an iterative process for interpretability may be required to force ML methods to fit models with specific interpretations. From the treatment perspective, an improved understanding of brain dynamics responsible for dysfunctional cognitive functions and/or maladaptive behaviors in mental illnesses is also critical. To find the hidden cause, it is useful to discuss the concept of "causality".

Neuroimaging also provides a passive sensing approach to observe the (correlational) brain-behavior relationship. However, correlation is not the same as causation. Correlational dependencies describe associations of measurements that experiments do not control, whereas causal dependencies link a dependent variable to an experimentally controlled variable. The key concept in causal inference is to introduce randomization to perturb the mapping. The relationship between every dependable variable and the randomized variable is causal, whereas the relationship between non-randomized variables and behavior, remains correlational [332] . Closed-loop experimental design would help to test the potential causality [333] . In human experiments, we classify closed-loop testing into two categories: one being fully automated, and the other being closedhuman-in-the-loop.

In this section, we will systematically review several important topics along these lines. We will review some "glass box" ML models in the literature (Section 7.1), provides a brief introduction on neuroimaging-based circuit-level modeling (Section 7.2), and adaptive neuromodulation (Section 7.3). We argue that combining these efforts in the loop ("Neuroimaging → Circuit modeling → Neurostimulation → Observing behaviors → Revising models", Fig. 10A ) will provide an effective way towards interpretable neuropsychiatry in understanding brain-behavior causation.

In terms of taxonomy, intrinsic interpretability refers to ML models that are considered interpretable due to their simple structure, such as short decision trees or sparse linear models (Fig. 10B ). Post-hoc interpretability refers to the application of interpretation methods after model training [334] . Interpretation may come with different forms: (i) finite feature summary statistics, (ii) meaningful model parameters, (iii) ease of visualization of model outcome (e.g., feature summary or decision boundary). An ML model that is highly interpretable because it has a few or more of the following properties for explanation [334] : high expressive power, low translucency, high portability, low algorithmic complexity and informative constraints. Generally, there is a trade-off between explainablity and performance. For instance, a constrained linear or bilinear model will fit many of these criteria, but the linear model does not warrant a good performance. Additionally, a model that is potentially explainable does not guarantee explainability. For example, co-dependence of input variables may make explanations ambiguous; latent variables of probabilistic generative model may face the problem of "explaining away" [335] .

There are several categories of interpretable ML models, which will be discussed briefly below. Hybrid rule-based ML models: This type of ML models can be used for generating rules, such as a decision rule set: IF (condition) THEN (outcome 1) ELSE (outcome 2) statement, where the conditional clause will be learned from the data [336] . This type of model has more expressive power but less portability.

Constrained ML models: This type of ML models imposes parameter constraints to either avoid overfitting or enhance interpretability. Examples of such include the constrained convolutional filters in the CNN [337] , or constrained mixture models [338] . As a result, these constrained models have low translucency.

Feedback ML models: ML models can be provided with user feedback in the human-in-the-loop system, where the user feedback is treated as constraints in the optimization problem [339] , [340] . The feedback can appear as a form of rule sets, which can be either known or unknown in advance. Iterating the feedback-rule optimization can generate more accurate rule sets. This type of model has good expressive power and high portability.

Sharing the same goal of XAI, computational psychiatry tries to combine multiple levels and types of computation with multiple types of data in an effort to improve understanding, prediction and treatment of mental illness [341] . Two complementary approaches are used in computational psychiatry: first, the data-driven approaches apply ML methods to high-dimensional data, multimodal to tackle classification and prediction problems (Section 3); second, the theory-driven approaches develop empirical or mechanistic models to test hypothesis.

For mechanistic modeling approaches, circuit-level mechanistic modeling of macroscopic or mesoscopic brain dynamics represents an important research topic in computational modeling for psychiatric disorders [342] - [344] . A common strategy is to first use a biologically-inspired model to simulate neural activity based on a network of interacting neural masses, and then within each brain area, to model the neuronal population activity as the Wilson-Cowan neural mass or the mean-field model, with each consisting of excitatory and inhibitory populations [345] . Furthermore, individual brain nodes are coupled according to the empirically-derived anatomical network [346] . The computational model can be driven by data (such as EEG and fMRI), or driven by hypothesis. One data-driven macroscopic level modeling approach is Dynamic causal modeling (DCM). DCM has been widely used in characterizing the effective connectivity of a functional network based on task or resting-state fMRI [347] , [348] , where the model parameter estimation and inference is done by unsupervised learning. By incorporating prior knowledge or hypotheses of network connections, DCM may reveal important brain mechanisms based on fMRI data and offer experimental predictions. One of potential applications of DCM is to characterize the neural plasticity in the human brain, especially the change in functional connectivity informed by neuroimaging studies. The functional connectivity can either change gradually during the course of tasks or behavioral protocols, or induced by perturbation or neurostimulation. These changes are often, but not always, associated with changes in functional activations of the studied brain regions. Specifically, combination of neuromodulation and DCM may provide a way to test the impact of neurostimulation on neural plasticity that underlies the change in adaptive or maladaptive behaviors.

One big challenge in human psychiatric neuroscience is the causality gap [349] . Statistical causality or Granger causality between two variables is not equivalent to brain-behavioral causality. To identify an effective treatment strategy for mental illnesses, it is critical to causally modulate neural circuitry that is responsible for maladaptive behaviors. Human neuroimaging alone only demonstrates correlations but not causation. To understand the causal mechanisms, it is important to close the loop in experiments by manipulating or perturbing the brain circuits and measuring its outcome, as commonly done in animal experiments [332] , [333] . Unfortunately, a rigorous and causal grounding of clinical symptoms and behavior in specific neural circuit alternations is still missing. Specifically, since the clinical symptoms are diverse, how to define the dimension of brain function that defines one or few clinical symptoms and effectively manipulate them remains unknown.

Causal and temporally precise neurostimulation tools provide a plausible tool to perturb or stimulate the brain by neuromodulation. To date, human neuromodulation methods include invasive deep brain stimulation (DBS), noninvasive transcranial magnetic stimulation (TMS), noninvasive transcranial direct/alternating current stimulation (tDCS/tACS), and transcranial focused ultrasound stimulation (tFUS). A review of advances in neuromodulation technologies for treating mental disorders can be found in the literature [350] - [352] . To date, repetitive TMS (rTMS) has been cleared by the FDA for the treatment of depression and recently used in the studies of neural functioning and behavior [353] , [354] .

The brain connectivity and dynamics can be studied from a network communication and control perspective [355] , [356] . The distinction between a healthy and a pathological brain can be characterized by their different ability or efficiency to route the information between distributed brain nodes, control/modulate the target node under specific constraints, or influence its behavior in order to perform specific tasks ("cognitive control") [357] . Brain connectivity and neurostimulation can be studied using the network and graph theory. Specifically, the control-theoretic models have also been applied to quantify the response of brain networks to exogenous and endogenous perturbations. Within the XAIneuromodulation framework, it is convenient to formulae a mathematical framework for important research questions: (i) can a target node stimulation rewire the brain connectivity in evoked and steady-state conditions? (ii) can the neurostimulation-induced change of evoked or resting-state brain connectivity distinguish a pathological from a healthy brain? (iii) Given an input constraint (such as the energy of neurostimulation), what is the optimal neurostimulation policy? Can alternate or simultaneous neurostimulations at multiple sites more effectively influence the network connectivity or bring additional benefit in treatment [358] ?

XAI for neurostimulation in mental health can be seen as an extension in the design of brain-machine interface (BMI) [359] . Specifically, XAI can search and identify behaviorally activated targets through active and scheduled stimulation strategies. Traditional neurostimulation strategies are designed in an on/off stimulation fashion triggered by predetermined stimulation parameters. However, these stimulation parameters will not be optimal. To accommodate an adaptive subject-specific stimulation strategy, adaptive stimulation uses neurofeedback to adjust the stimulation parameters or control policy for achieving various optimality criteria; reinforcement learning and active learning (two other important ML topics not reviewed here) can play a crucial role in online adaptive experiments [360] , [361] . Additionally, simultaneous or post-stimulation neuroimaging provides a window of examining the change in brain network connectivity patterns. Can the induced brain patterns or changes in network connectivity be used to predict the treatment outcome? ML provides a potential tool to address such a question by providing individualized treatment-response likelihood in precision psychiatry [362] .

The past few decades have witnessed growing interests and rapid developments in ML methods toward precision psychiatry. However, caution has been raised regarding the unrealistic hope for ML applications in clinical practice [160] , [363] , and the field is facing both conceptual and practical challenges.

At the conceptual level, first, the term "disorder" was used to specifically avoid the term "disease," which implies a level of neurobiological and physiological understanding that is lacking in psychiatry. This makes it very challenging to build clinical inference models for mental disorders since the neurological and physiological mechanisms are not always observable with sufficient precision. For example, this precision is limited due to the temporal and spatial limitations of neuroimaging methods. As a result, it is not yet feasible to develop treatments that target underlying physiological risk factors similar to how it is possible in other areas of medicine, for example, treating hypertension since it plays a causal role in heart disease. Furthermore, each mental disorder has various types of overlapping symptoms with varying degrees, bringing an additional challenge to uniquely define the disorder in psychiatry (unlike a clear cut in cardiology or oncology).

Second, many disorders are presented as a spectrum, for example, autism spectrum disorder, generalized anxiety spectrum, and schizophrenia spectrum, and presented differently in different patients, creating a wide range of subtypes and subject variability diagnosed with the same mental disorder. Third, due to various genetic, biochemical, neuropathological factors, the same mental disorder may have different causes and symptoms in different patients. Fourth, many mental disorders have overlapping symptoms with other physical or mental disorders [364] . For example, changes in sleep and energy level, often found in depression and generally measured using the PHQ-9 questionnaire, are very common across many other disorders. This makes it challenging to accurately diagnose mental disorders. One of the challenges of precision psychiatry is to fully dissect the mechanisms and reveal the one-to-one relationship. This can be catalyzed by rigorous and continuous measurements of factors relevant to mental health using novel data sources as described in this article.

At the practical level, many challenges remain in effective applications of ML in mental health.

Sample size. Datasets used in ML applications often have very small sample sizes, especially by the standard of other speech/image/video applications. Neuroimaging data collection from mental health patients is limited to one-shot examples, which makes the data highly noisy in addition to the intrinsic heterogeneity or disease comorbidity. Recent developments in foundation models and their applications to mental health domain can help overcome this challenge to some degree-for example, by sharing pretrained language models [216] . However, further caution is needed to ensure appropriate validation methods on the problem-specific data. For example, studies which do not hold out all data from specific patients for validation can lead to incorrect conclusions.

Data quality. There is a lack of standardization in data acquisition and uneven data quality, bringing up the issues of rigor and reproducibility. For example, in many studies using social media data, mental disorders self-identified by users are used as labels in the absence of clinical labels. This can lead to a post containing: "I am depressed", being labeled as a positive class for depression regardless of the underlying clinical symptoms. Terms such as "depressed" or "anxious" have colloquial uses which can differ from clinical usage, leading to a highly noisy dataset. Furthermore, such studies also make it very challenging to generate data for a healthy control class since a lack of mention about a disorder does not rule out its presence. Because of these reasons, the interpretation of many results reported today should be cautioned.

Data privacy and security. Advances in sensing technologies can collect a large amount of personal and sensitive data, whether it is location data, face images, speech conversations, or social interactions. How to collect, store and process these data without the leakage risk of privacy information remains an important challenge for advancing ML research. While research studies have oversights like internal review boards to assure the ethical use of such data, this type of data is collected in the most massive scale by large tech and social media companies. Existing regulations do not treat this data as personally identifiable information (PII) which can be used to inform the user's health. This is a major challenge in securing identifiable user data. If overcome, this will enable large-scale mental health research based on this data. To make this possible, U.S regulations such as the Health Insurance Portability and Accountability Act (HIPAA) can be used to govern PII acquired by all commercial entities or social media companies.

Social implications and environmental factors. Factors like gender are a critical determinant of mental health. According to WHO, mental disorders have a history of gender bias. First, in terms of gender risk factors, females are more likely to suffer from depression and anxiety; whereas there is prevalence of autism in males. Second, in terms of gender treatment bias, doctors are more likely to diagnose depression in women compared with men, and women are more likely to be prescribed with mood altering psychotropic drugs. ML can play a role in uncovering gender risk factors and minimize the diagnosis or treatment bias related to social factors like gender and race.

Generalizability. The classic ML challenge of generalization applies very deeply to ML applications in mental health, especially due to the challenges like Sample size and Data quality. Most studies use cross validation methods to avoid overfitting on their data but do not go out to collect new data "in the wild" to assess generalizability. Furthermore, very few studies test generalization across data sources and research institutions. For example, it is important to test how well do models built using speech from clinical interviews apply to non-clinical speech data.

Algorithmic bias. Digital mental health inherits the long history of bias in psychiatry, which is present at all stages of a patient journey [365] . This poses a major challenge in developing ML applications for mental health, making the effect of algorithmic bias possibly worse than other fields of medicine. In addition to biological underpinnings, the domains of data (such as language) also represent social underpinnings [366] , and so it is important to consider how socioeconomic factors are influencing measurements. Using training and validation sets that are representative across all demographics including race, gender, and age can help address some of the issues with bias while also uncovering new learning about symptom expressions in various groups and allowing variability in modeling approaches for various groups. This is even more important for ML approaches that inherit bias from other ML models.

Interpretability. The ability to understand which latent factors are contributing most to the outcome is the key for advancing clinical understanding of mental disorders by mental health professionals as well as for the users of mental health technology to feel agency and trust. This is also an important dimension to improve "precision" in mental health. The choice of the interpretation method [331] , like model-specific (such as analyzing attention weights of a transformer), or model agnostic (such as local interpretable model-agnostic explanations (LIME)), is very specific to the nature of the problem. While various interpretation methods can be used to learn about model functioning, it is important to note that the interpretation results can only be trusted as long as the challenges of generalizability and data quality are addressed. In other words, model interpretation methods can produce erratic results with insufficient or poorquality data.

Causal inference. Most ML applications in mental health have focused on consuming more information from various data sources compared to a mental health professional and reaching a diagnosis decision faster. However, diagnosing a mental disorder, even with a highly interpretable model, does not speak to the underlying causes and thus has limited implications on treatment design, which is focused on treating the causes. Causal inference methods supported by ML models [367] can help with "precision" treatment design [368] , which is the next step in the patient's journey after precision diagnosis. Recent developments in ultra-high-field neuroimaging [369] can provide a pathway for developing inference models for mental disorders by observing their underlying neural mechanisms with sufficient temporal and spatial precision.

Clinical integration. Many ML-based studies have deployed limited experimental datasets. While structuring experiments and challenges for developing ML applications in mental health, it is important to consider the clinical need from both a user experience point of view as well as for key factors such as sources of data, size of held out datasets, and so on. From a user experience point of view, it is important to consider both the mental health professionals using the application [370] as well as their patients [371] . Some of this work, like running user research in various demographics, lies outside of the ML domain; however, such cross-functional research can inform best practices in developing ML models. This type of thinking with the end goal in mind is important for successful translation of precision psychiatry research to widespread clinical practice [372] .

Ethical considerations. ML applications in mental health raises several important ethical considerations. For example, ML models for risk assessment can lead to early screening that can in theory help with starting treatment early [8] . However, when screening techniques are available outside clinical settings, it also creates the risk of misinterpretation by patients, which can negatively affect treatment seeking behavior or can trigger self-harming thoughts in patients. Other ethical questions related to increasing the risk of self-harm arise inherently from using ML approaches that use foundation models like GPT-3 (Generative Pre-trained Transformer 3), which should be fully considered before deployment in clinical settings [373] .

Aside from the opportunities arising from the abovementioned challenges, precision psychiatry is also accompanied by plenty of new opportunities, especially in future ML applications.

Data-centric approach. The data-driven ML view ("ML system = model/algorithm + data"), data is powerful. However, medical data are costly to collect and noisy. Currently, there is an ML paradigm shift from model-centric to datacentric, using good "small" data instead of simply collecting from big but possibly noisy data. The good quality criteria include: (i) consistency; (ii) coverage of important cases; (iii) inclusion of timely feedback from user or production data. Unlike the model-centric ML approach that focuses on modifying the model/algorithm (while fixing the data) to improve the performance, a data-centric ML approach (https://datacentricai.org/) involves building ML systems with quality data, with a goal to systematically process/augment the data (while fixing the model) to improve the ML performance [374] . The modification of the available data may include data regeneration, data augmentation, and label refinement strategies to improve the data consistency. The process of two approaches can be iterative and bootstrap the system performance.

Data augmentation approach. To deal with the small sample size issue in the medical field, another independent ML approach is to create synthetic data (as the data augmentation strategy) for ML [375] . Deep learning methods such as GAN and its variants have proved a powerful tool to generate synthetic brain images, speech, video, physiological data, and EHRs [376] - [378] .

Automated learning approach. In contrast to the human-in-the-loop solutions, automated machine learning (autoML) and automated deep learning (autoDL) represent a new paradigm that aims to automate the data analysis pipeline while minimizing the need of human intervention during the course of modeling and training [379] . This has become increasingly important as the volume of social media and multimedia data streams is overwhelming and prohibitive for human effort.

Data integration approach. Integration of multimodal data is critical for psychiatric diagnostics and monitoring. Therefore, the development of weakly supervised, interpretable, multimodal deep learning pipelines to fuse histopathology, genomics, neuroimaging, and behavioral data, or the development of multimodal fusion algorithms for speech, video, and EHRs to assist both psychiatrists and patients is urgently needed. Because of the multimodality, not all data can be quantified in the Euclidean space, graph or geometric deep learning can play a role towards this research direction [380] , [381] .

To date, there is still a lack of biomarkers and individualized treatment guidelines for mental illnesses. As reviewed in this paper, we have shown that ML technologies can be used for various stages in data analytics: detection/diagnosis, treatment selection/optimization, outcome monitoring/tracking, and relapse prevention. We predict that the multimodal integration of modernized neuroimaging, ML, genetics, behavioral neuroscience, and mobile health will open doors for new method development and technology inventions. First, making brain scans more accessible and more accurate will be the key to clinical applications of neuroimaging techniques. Using real-time fMRI, ML can guide neurofeedback-based intervention and provide closed-loop treatment or rehabilitation. As a "real-time mirror" of psychiatry, mind-control intervention can improve behavioral outcomes. Second, data-driven ML methods can be applied to identify subtypes of its symptoms and cognitive deficits, and develop model-based phenotyping [382] . Third, ML methods, combined with large electronic health databases, could enable a personalized approach to psychiatry through improved diagnosis and prediction of individual responses to therapies. Finally, a combination of medications, wearable devices, mobile health apps, social support, and online education will be essential to improve mental health or assist therapeutic outcomes in treating mental disorders in the new era of digital psychiatry. Future precision psychiatry will leverage ML and new technologies to provide individualized custom packages that are built upon patient choice or need and specific neural pathology.

Mental health, substance use, and suicidal ideation during the COVID-19 pandemic-United States

Brain disorders? precisely

The new field of 'precision psychiatry

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

Machine learning for precision psychiatry: opportunities and challenges

Machine learning methods in psychiatry: a brief introduction

Synthesising artificial patient-level data for open science-an evaluation of five methods

Digital psychiatry: Risks and opportunities for public health and wellbeing

Artificial intelligence and the future of psychiatry: Insights from a global physician survey

Machine learning and big data in psychiatry: toward clinical applications

Using machine learning in psychiatry: the need to establish a framework that nurtures trustworthiness

Data science in the research domain criteria era: relevance of machine learning to the study of stress pathology, recovery, and resilience

Machine learning in mental health: a scoping review of methods and applications

Deep learning in mental health outcome research: a scoping review

A brief review of artificial intelligence applications and algorithms for psychiatric disorders

Machine learning in mental health: A systematic review of the hci literature to support the development of effective and implementable ml systems

Deep neural networks in psychiatry

Deep learning for small and big data in psychiatry

Machine learning for psychiatry: getting doctors at the black box?

Machine learning for genetic prediction of psychiatric disorders: a systematic review

Artificial intelligence and the future of psychiatry

Soft ultrathin silicon electronics for soft neural interfaces: A review of recent advances of soft neural interfaces based on ultrathin silicon

Mind-brain dualism in psychiatry: ethical implications

A reckoning and research agenda for neuroimaging in psychiatry

Neuroimaging

Neural correlates of delay discount alterations in addiction and psychiatric disorders: a systematic review of magnetic resonance imaging studies

Advances in neuroimaging

Are there progressive brain changes in schizophrenia? a meta-analysis of structural magnetic resonance imaging studies

Magnetic resonance diffusion tensor imaging in psychiatry: A narrative review of its potential role in diagnosis

Resting-state fMRI in the human connectome project

Opportunities in precision psychiatry using pet neuroimaging in psychosis

Electroencephalography and event-related potential biomarkers in individuals at clinical high risk for psychosis

Recent advances in functional neuroimaging analysis for cognitive neuroscience

Human intracranial EEG: Promises and limitations

Mood variations decoded from multi-site intracranial human brain activity

Closedloop neuromodulation in an individual with treatment-resistant depression

A brief review on the history of human functional near-infrared spectroscopy (fnirs) development and fields of application

Functional near-infrared spectroscopy in developmental psychiatry: a review of attention deficit hyperactivity disorder

Reward processing in depression: a conceptual and metaanalytic review across fMRI and EEG studies

Neural correlates of emotional processing in psychosis risk and onset-a systematic review and meta-analysis of fMRI studies

Functional connectomics from resting-state fMRI

Resting-state functional connectivity in psychiatric disorders

Dynamic changes of spatial functional network connectivity in healthy individuals and schizophrenia patients using independent vector analysis

Brain dynamics: the temporal variability of connectivity, and differences in schizophrenia and ADHD

Multimodal fusion of brain imaging data: a key to finding the missing link (s) in complex mental illness

The heterogeneity problem: approaches to identify psychiatric subtypes

Parsing psychiatric heterogeneity through common and unique circuit-level deficits

The nimh research domain criteria (RDoC) project: precision medicine for psychiatry

The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology

Parcellating cortical functional networks in individuals

Translational machine learning for psychiatric neuroimaging

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography

Resting-state brain oscillations predict cognitive function in psychiatric disorders: A transdiagnostic machine learning approach

The neural correlates of transdiagnostic dimensions of psychopathology

Linked dimensions of psychopathology and connectivity in functional brain networks

Somatosensory-motor dysconnectivity spans multiple transdiagnostic dimensions of psychopathology

Identification of common neural circuit disruptions in emotional processing across psychiatric disorders

A longitudinal imaging genetics study of neuroanatomical asymmetry in alzheimer's disease

Bidirectional associations between stress and reward processing in children and adolescents: a longitudinal neuroimaging study

Neural contributors to trauma resilience: a review of longitudinal neuroimaging studies

A dynamic graph convolutional neural network framework reveals new insights into connectome dysfunctions in ADHD

Multimodal neuroimaging-based prediction of adult outcomes in childhoodonset ADHD using ensemble learning techniques

Braingnn: Interpretable brain graph neural network for fMRI analysis

Ensemble learning with 3d convolutional neural networks for functional connectome-based prediction

Identification and individualized prediction of clinical phenotypes in bipolar disorders using neurocognitive data, neuroimaging scans and machine learning

Multivariate classification of earthquake survivors with post-traumatic stress disorder based on large-scale brain networks

Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site fMRI data

Machine learning classification of first-episode schizophrenia spectrum disorders and controls using whole brain white matter fractional anisotropy

Major depressive disorder classification based on different convolutional neural network models: Deep learning approach

Identification of autism spectrum disorder using deep learning and the abide dataset

Disease prediction using graph convolutional networks: application to autism spectrum disorder and alzheimer's disease

Individual patterns of abnormality in resting-state functional connectivity reveal two data-driven PTSD subgroups

Can we use neuroimaging data to differentiate between subgroups of children with ADHD symptoms: A proof of concept study using latent class analysis of brain activity

Transdiagnostic dimensions of psychopathology explain individuals' unique deviations from normative neurodevelopment in brain structure

Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression

Prediction of psychosis using neural oscillations and machine learning in neuroleptic-naïve at-risk patients

Use of machine learning for predicting escitalopram treatment outcome from electroencephalography recordings in adult patients with depression

Predicting the naturalistic course of major depressive disorder using clinical and multimodal neuroimaging information: a multivariate pattern recognition study

Reward-related neural activity and structure predict future substance use in dysregulated youth

Predicting ptsd severity using longitudinal magnetoencephalography with a multi-step learning framework

Deep learning model of fMRI connectivity predicts PTSD symptom trajectories in recent trauma survivors

Multi-center mri prediction models: Predicting sex and illness course in first episode psychosis patients

Comparing machine and deep learning-based algorithms for prediction of clinical improvement in psychosis with functional magnetic resonance imaging

An electroencephalographic signature predicts antidepressant response in major depression

Brain regulation of emotional conflict predicts antidepressant treatment response for depression

Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition

Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD

Individual prediction of psychotherapy outcome in posttraumatic stress disorder using neuroimaging data

Brain responses to biological motion predict treatment outcome in young children with autism

Multivariate resting-state functional connectivity predicts response to cognitive behavioral therapy in obsessive-compulsive disorder

Treatment response prediction and individualized identification of first-episode drug-naive schizophrenia using brain functional connectivity

Predicting rehospitalization within 2 years of initial patient admission for a major depressive episode: a multimodal machine learning approach

High-risk phenotypes of early psychiatric readmission in bipolar disorder with comorbid medical illness

Predicting hospital readmission in patients with mental or substance use disorders: a machine learning approach

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis

Recommendations and future directions for supervised machine learning in psychiatry

Evaluating the machine learning literature: a primer and user's guide for psychiatrists

Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry

A scoping review of machine learning in psychotherapy research

Machine learning with neuroimaging: Evaluating its applications in psychiatry

Neuroimagingbased individualized prediction of cognition and behavior for mental disorders and health: methods and promises

A survey on deep learning for neuroimaging-based brain disorder analysis

Review of machine learning algorithms for diagnosing mental illness

Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity

Using connectome-based predictive modeling to predict individual behavior from brain connectivity

Sparse Bayesian learning and the relevance vector machine

Sparse bayesian classification of EEG for brain-computer interface

Classification of multi-site mr images in the presence of heterogeneity using multi-task learning

A manifold regularized multi-task learning model for iq prediction from two fMRI paradigms

Multi-task learning based structured sparse canonical correlation analysis for brain imaging genetics

Multivariate neuroanatomical correlates of behavioral and psychological symptoms in dementia and the moderating role of education

Towards artificial intelligence in mental health by improving schizophrenia prediction with multiple brain parcellation ensemble-learning

Multi-class asd classification based on functional connectivity and functional correlation tensor via multi-source domain adaptation and multi-view sparse representation

Using the beta distribution in group-based trajectory models

An overview of mixture modelling for latent evolutions in longitudinal data: Modelling approaches, fit statistics and software

Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use

A latent trajectory analysis of inpatient depression treatment

Identifying autism symptom severity trajectories across childhood

A validated predictive algorithm of post-traumatic stress course following emergency department admission after a traumatic stressor

Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis

Understanding heterogeneity in clinical cohorts using normative models: beyond case-control studies

The normative modeling framework for computational psychiatry

Semi-Supervised Learning

Hydra: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework

Probing the clinical and brain structural boundaries of bipolar and major depressive disorder

Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods

Neurostructural heterogeneity in youths with internalizing symptoms

A semi-supervised autoencoder for autism disease diagnosis

Semi-supervised learning of the electronic health record for phenotype stratification

Semi-supervised approach to monitoring clinical depressive symptoms in social media

Semi-supervised graph instance transformer for mental health inference

A multimodal neuroimaging classifier for alcohol dependence

Semi-supervised learning of the electronic health record for phenotype stratification

Deep learning in medical image analysis

Deep learning encodes robust discriminative neuroimaging representations to outperform standard machine learning

Deep learning applications for the classification of psychiatric disorders using neuroimaging data: systematic review and metaanalysis

Identifying and validating subtypes within major psychiatric disorders based on frontal-posterior functional imbalance via deep learning

ASD-SAENet: a sparse autoencoder, and deep-neural network model for detecting autism spectrum disorder (ASD) using fMRI data

Using deep autoencoders to identify abnormal brain structural patterns in neuropsychiatric disorders: A large-scale multi-sample study

Medical image analysis using convolutional neural networks: a review

Convolutional neural networks: an overview and application in radiology

Three dimensional convolutional neural network-based classification of conduct disorder with structural mri

Graph neural networks in network neuroscience

Psychiatric illnesses as disorders of network dynamics

4D modeling of fMRI data via spatio-temporal convolutional neural networks (ST-CNN)

Data augmentation for deep-learning-based electroencephalography

Vigan: Missing view imputation with generative adversarial networks

Jointly discriminative and generative recurrent neural networks for learning from fMRI

Functional network connectivity (FNC)-based generative adversarial network (GAN) and its applications in classification of mental disorders

Machine intelligence in healthcare-perspectives on trustworthiness, explainability, usability, and transparency

Fear-induced brain activations distinguish anxious and traumaexposed brains

Telehealth: A quarter-trillion-dollar post-covid-19 reality

Artificial intelligence for mental health care: clinical applications, barriers, facilitators, and artificial wisdom

Big Data in Psychiatry and Neurology

Artificial intelligence for mental health and mental illnesses: an overview

Digital measurement of mental health: challenges, promises, and future directions

Improving mental health services: A 50-year journey from randomized experiments to artificial intelligence and precision mental health

Time to reality check the promises of machine learning-powered precision medicine

Reading Our minds: The rise of Big data psychiatry. Columbia Global Reports

Automatic detection of depression in speech using ensemble convolutional neural networks

Speech-based depression prediction using encoderweight-only transfer learning and a large corpus

Investigation of speech landmark patterns for depression detection

Automated depression diagnosis based on deep networks to encode facial appearance and dynamics

A multi-modal gait analysis-based depression detection system

Robust speech and natural language processing models for depression screening

Facebook language predicts depression in medical records

Multi-modal adaptive fusion transformer network for the estimation of depression level

Vocal features obtained through automated methods in verbal fluency tasks can aid the identification of mixed episodes in bipolar disorder

Detecting bipolar depression from geographic location data

Speechbased markers for posttraumatic stress disorder in us veterans

A multimodal approach for predicting changes in ptsd symptom severity

Non-verbal speech cues as objective measures for negative symptoms in patients with schizophrenia

Computer vision-based assessment of motor functioning in schizophrenia: Use of smartphones for remote measurement of schizophrenia symptomatology

Utilizing machine learning on internet search activity to support the diagnostic process and relapse detection in young individuals with early psychosis: feasibility study

Acoustic and facial features from clinical interviews for machine learning-based psychiatric diagnosis: Algorithm development

Sensing technologies for monitoring serious mental illnesses

Manic depressive insanity and paranoia

Automated assessment of psychiatric disorders using speech: A systematic review

The geneva minimalistic acoustic parameter set (GeMAPS) for voice research and affective computing

A review of depression and suicide risk assessment using speech analysis

Ecologically valid long-term mood monitoring of individuals with bipolar disorder using speech

Cross-demographic portability of deep NLP-based depression models

AI can now detect depression from your voice, and it's twice as accurate as human practitioners

Sonde launches voice API to detect mental illness

Validation of visual and auditory digital markers of suicidality in acutely suicidal psychiatric inpatients: Proof-of-concept study

Human behaviour-based automatic depression analysis using hand-crafted statistics and deep learned spectral features

Computer vision in autism spectrum disorder research: a systematic review of published studies from

Sequential fusion of facial appearance and dynamics for depression recognition

Deep learning for depression recognition with audiovisual cues: A review

Visually interpretable representation learning for depression recognition from facial images

Language, speech, and facial expression features for artificial intelligencebased detection of cancer survivors' depression: Scoping metareview

Natural language processing in psychiatry: the promises and perils of a transformative approach

Machine learning and natural language processing in mental health: Systematic review

National electronic health records survey: 2015 specialty and overall physicians electronic health record adoption summary tables

Validation of electronic health record phenotyping of bipolar disorder cases and controls

Risk prediction using natural language processing of electronic mental health records in an inpatient forensic psychiatry setting

Predicting suicide attempts in adolescents with longitudinal clinical data and machine learning

Predicting early psychiatric readmission with natural language processing of narrative discharge summaries

Applied natural language processing in mental health big data

Generation and evaluation of artificial mental health records for natural language processing

Just in time crisis response: suicide alert system for telemedicine psychotherapy settings

Natural language processing of helpline chat data before and during the pandemic revealed significant decrease in self-image appreciation and changes in other traits

Natural language processing markers in first episode psychosis and people at clinical high-risk

Depression and anxiety prediction using deep language models and transfer learning

Historical language records reveal a surge of cognitive distortions in recent decades

Individuals with depression express more distorted thinking on social media

A deep learning model for detecting mental illness from user content on social media

Understanding and measuring psychological stress using social media

A survey of computational methods for online mental state assessment on social media

Utilizing instagram data to identify usage patterns associated with schizophrenia spectrum disorders

Identifying signals associated with psychiatric illness utilizing language and images posted to facebook

CairoDep: Detecting depression in arabic posts using bert transformers

BERT-based transformers for early detection of mental health illnesses

Mentalbert: Publicly available pretrained language models for mental healthcare

Natural language analyzed with ai-based transformers predict traditional subjective well-being measures approaching the theoretical upper limits in accuracy

Methods in predictive techniques for mental health status on social media: a critical review

Mental health monitoring with multimodal sensing and machine learning: A survey

Digital biomarkers of cognitive function

Predicting mood disturbance severity with mobile phone keystroke metadata: a biaffect digital phenotyping study

The potential of game-based digital biomarkers for modeling mental health

Assessing social anxiety through digital biomarkers embedded in a gaming task

Apple is working on iphone features to help detect depression, cognitive decline

Mobile phone and wearable sensor-based mhealth approaches for psychiatric disorders and symptoms: systematic review

Detecting depression and predicting its onset using longitudinal symptoms captured by passive sensing: a machine learning approach with robust feature selection

New tools for new research in psychiatry: a scalable and customizable platform to empower data driven smartphone research

Personal sensing: understanding mental health using ubiquitous sensors and machine learning

Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety

A therapeutic relational agent for reducing problematic substance use (woebot): development and usability study

Amazon announces halo, a fitness band and app that scans your body and voice

Understand your stress so you can manage it

Kintsugi for health plans

Mental health goes mobile: The mental health app market will keep on growing

The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality

Harnessing smartphone-based digital phenotyping to enhance behavioral and mental health

Mental health in a digital world

Digital measurement of mental health: Challenges, promises, and future directions

636,120 ways to have posttraumatic stress disorder

Serotonin, motor activity and depression-related disorders

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism

Validation of visual and auditory digital markers of suicidality in acutely suicidal psychiatric inpatients: Proof-of-concept study

Remote digital measurement of facial and vocal markers of major depressive disorder severity and treatment response: a pilot study

Facial and vocal markers of schizophrenia measured using remote smartphone assessments: Observational study

Estimation of clinical tremor using spatio-temporal adversarial autoencoder

Quantifying the association between psychotherapy content and clinical outcomes using deep learning

Improvements in stress, affect, and irritability following brief use of a mindfulness-based smartphone app: a randomized controlled trial

Association between care utilization and anxiety outcomes in an on-demand mental health system: Retrospective observational study

Understanding the relationship between patient language and outcomes in internet-enabled cognitive behavioural therapy: A deep learning approach to automatic coding of session transcripts

Automated quality assessment of cognitive behavioral therapy sessions through highly contextualized language representations

Characteristics and challenges of the clinical pipeline of digital therapeutics

Bending the curve for mental health: technology for a public health approach

The transition of academic mental health clinics to telehealth during the covid-19 pandemic

Internet-based versus face-to-face cognitive-behavioral intervention for depression: a randomized controlled non-inferiority trial

Multimodal data fusion: an overview of methods, challenges, and prospects

Fusing in vivo and ex vivo nmr sources of information for brain tumor classification

Multimodal data fusion using source separation: Two effective models based on ICA and IVA and their properties

Multimodal data fusion using source separation: Application to medical imaging

Multimodal fusion signature as transdiagnostic psychiatric biomarker

Advances in multimodal data fusion in neuroimaging: overview, challenges, and novel orientation

Canonical correlation analysis for data fusion and group inferences

Multiway canonical correlation analysis of brain data

Joint blind source separation for neurophysiological data analysis: Multiset and multimodal methods

How to integrate data from multiple biological layers in mental health?" in Personalized Psychiatry

Linked component analysis from matrices to high-order tensors: Applications to biomedical data

Feature-based fusion of medical imaging data

A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data

Data fusion in metabolomics using coupled matrix and tensor factorizations

Group component analysis for multiblock data: Common and individual feature extraction

Joint and individual variation explained (JIVE) for integrated analysis of multiple data types

Simplemkl

Unsupervised multiple kernel learning for heterogeneous data integration

Classification of first-episode psychosis in a large cohort of patients using support vector machine and multiple kernel learning techniques

Multimodal analysis of functional and structural disconnection in a lzheimer's disease using multiple kernel svm

Multimodal classification of alzheimer's disease and mild cognitive impairment

Deep multimodal learning: A survey on recent advances and trends

Effective feature learning and fusion of multimodality data using stage-wise deep neural network for dementia diagnosis

A deep manifoldregularized learning model for improving phenotype prediction from multi-modal data

Towards multi-modal causability with graph neural networks enabling information fusion for explainable ai

M-GCN: A multimodal graph convolutional network to integrate functional and structural connectomics data to predict multidimensional phenotypic characterizations

Deep representation learning for multimodal brain networks

Multiplex graph networks for multimodal brain network analysis

Multimodal neuroimaging: basic concepts and classification of neuropsychiatric diseases

Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model

Unraveling diagnostic biomarkers of schizophrenia through structure-revealing fusion of multi-modal neuroimaging data

Predicting differential diagnosis between bipolar and unipolar depression with multiple kernel learning on multimodal structural neuroimaging

Multimodal mri-based classification of trauma survivors with and without post-traumatic stress disorder

Multimodal MR images-based diagnosis of early adolescent attentiondeficit/hyperactivity disorder using multiple kernel learning

Fusing multimodal neuroimaging data with a variational autoencoder

Mmm: classification of schizophrenia using multi-modality multi-atlas feature representation and multi-kernel learning

Reading the (functional) writing on the (structural) wall: Multimodal fusion of brain structure and function via a deep neural network based translation approach reveals novel impairments in schizophrenia

Multi-modal deep learning of functional and structural neuroimaging and genomic data to predict mental illness

Association of neuroimaging data with behavioral variables: A class of multivariate methods and their comparison using multitask fMRI data

Emotion transformer fusion: Complementary representation properties of EEG and eye movements on recognizing anger and surprise

Multi-task, multikernel learning for estimating individual wellbeing

Context-aware deep learning for multi-modal depression detection

Automatic assessment of emotion dysregulation in american, french, and tunisian adults and new developments in deep multimodal fusion: Cross-sectional study

Identifying behavioral phenotypes of loneliness and social isolation with passive sensing: statistical analysis, data mining and machine learning of smartphone and fitbit data

A unimodal reinforced transformer with time squeeze fusion for multimodal sentiment analysis

Dynamic multimodal measurement of depression severity using deep autoencoding

Understanding and predicting antidepressant response: Using animal models to move toward precision psychiatry

The critical importance of basic animal research for neuropsychiatric disorders

Sex-specific transcriptional signatures in human depression

Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons

Mechanisms of stress in the brain

Distinct proteomic, transcriptomic, and epigenetic stress responses in dorsal and ventral hippocampus

Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance

Antidepressant epigenetic action

Integrative single-cell analysis

Machine learning and statistical methods for clustering single-cell rna-sequencing data

Integrated analysis of multimodal single-cell data

Exploring single-cell data with deep multitasking neural networks

Single-cell rna-seq denoising using a deep count autoencoder

Vasc: Dimension reduction and visualization of single-cell rna-seq data by deep variational autoencoder

Data denoising with transfer learning in single-cell transcriptomics

Joint profiling of chromatin accessibility and gene expression in thousands of single cells

High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell

High-definition spatial transcriptomics for in situ tissue profiling

Slide-seq: A scalable technology for measuring genomewide expression at high spatial resolution

An emerging epigenetic framework of systemic and central mechanisms underlying stress-related disorders

Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance

Multidimensional predictors of antidepressant responses: Integrating mitochondrial, genetic, metabolic and environmental factors with clinical outcomes

Multi-omic biomarker identification and validation for diagnosing warzone-related posttraumatic stress disorder

Predeployment risk factors for ptsd in active-duty personnel deployed to afghanistan: a machine-learning approach for analyzing multivariate predictors

Computational analysis of multidimensional behavioral alterations after chronic social defeat stress

Highthroughput analysis of behavior for drug discovery

Multidimensional predictors of susceptibility and resilience to social defeat stress

DARPA's explainable artificial intelligence (XAI) program

Taming the chaos?! using explainable artificial intelligence (xai) to tackle the complexity in mental health research

Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: a retrospective study of high-frequency data in electronic patient records

Illuminating the black box: Interpreting deep neural network models for psychiatric research

Navigating the neural space in search of the neural code

Improving scalability in systems neuroscience

Interpretable Machine Learning: A Guide for Making Black Box Models Explainable

Probabilistic Reasoning in Intelligent Systems: Networks of Plausible Inference

Interpretable classifiers using rules and bayesian analysis: Building a better stroke prediction model

Targeting EEG/LFP synchrony with neural nets

Priors for diversity in generative latent variable models

What changed? interpretable model comparison

User driven model adjustment via boolean rule explanation

Computational psychiatry as a bridge from neuroscience to clinical applications

Dynamic models of large-scale brain activity

Biophysical modeling of large-scale brain dynamics and applications for computational psychiatry

Relations between large-scale brain connectivity and effects of regional stimulation depend on collective dynamical state

Excitatory and inhibitory interactions in localized populations of model neurons

A large-scale circuit mechanism for hierarchical dynamical processing in the primate cortex

Dynamica causal modeling

A DCM for resting state fMRI

Addressing the causality gap in human psychiatric neuroscience

Brain neuromodulation techniques: a review

Information-based approaches of noninvasive transcranial brain stimulation

Closed-loop neuromodulation systems: next generation treatments for psychiatric illness

Causal interactions between fronto-parietal central executive and default-mode networks in humans

Causal inferences in repetitive transcranial magnetic stimulation research: challenges and perspectives

Control of dynamics in brain networks

Models of communication and control for brain networks: distinctions, convergence, and future outlook

Data-driven approaches to neuroimaging analysis to enhance psychiatric diagnosis and therapy

Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases

Explainable artificial intelligence for neuroscience: behavioral neurostimulation

Treating epilepsy via adaptive neurostimulation: a reinforcement learning approach

Learning to control the brain through adaptive closed-loop patterned stimulation

Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: a resting state electroencephalography study

Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness

Prevalence, severity, and comorbidity of 12-month dsm-iv disorders in the national comorbidity survey replication

From treatment to healing: Envisioning a decolonial digital mental health

More than a biomarker: could language be a biosocial marker of psychosis?

When causal inference meets deep learning

Causal inference and counterfactual prediction in machine learning for actionable healthcare

7T ultra-high-field neuroimaging for mental health: an emerging tool for precision psychiatry?

AI in health and medicine

Consumer willingness to share personal digital information for health-related uses

The crossroads of digital phenotyping

Considering the possibilities and pitfalls of generative pre-trained transformer 3 (gpt-3) in healthcare delivery

What can data-centric ai learn from data and ml engineering

Synthetic data in machine learning for medicine and healthcare

Generative adversarial networks and its applications in biomedical informatics

Deep learning for robust detection of interictal epileptiform discharges

Generation of synthetic electronic health records using a federated gan

Recent advances of deep learning in psychiatric disorders

Deep learning on graphs: A survey

Geometric deep learning: Grids, groups, graphs, geodesics, and gauges

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

The research was partially supported from the US National Science Foundation (CBET-1835000 to Z.S. Chen), the National Institutes of Health (R01-NS121776 and R01-MH118928 to Z.S. Chen). We thank Robert MacKay for English proofreading.